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ABSTRACT 
Herpes simplex virus type 1 is a common neurotropic pathogen responsible for a 
multitude of human diseases ranging from mucocutaneous lesions, keratitis to life-threatening 
encephalitis. The hallmark of the HSV-1 life cycle is infection of sensory neurons, where the 
virus establishes a latent infection for the life of the host. Viral envelope glycoproteins play 
important roles in viral life cycle and virus-host interaction. Viral glycoproteins gK, gM, gE and 
the membrane protein UL11 have been shown to be important for virus assembly, egress and 
virus spread. To investigate the relative importance of each of gK, gM, gE and UL11 in infection 
of ganglionic neurons following ocular inoculation, recombinant viruses were constructed, 
characterized and used to infect mice via the ocular route. Results showed that gK plays the 
most important role in infection of ganglionic neurons following ocular inoculation in the 
mouse model. gK null viruses exhibited major defects in replication and cell to cell spread in 
tissue culture. To further investigate the role of gK in the pathogenesis of herpes keratitis and 
to delineate gK domains responsible for replication and neuroinvasion, recombinant viruses 
lacking the amino-terminus of gK were constructed. Characterization of the constructed viruses 
revealed that the amino terminus of gK is dispensable for replication in tissue culture; however, 
it is required for neuroinvasion and cell to cell spread. Moreover, the virus lacking the amino 
terminus in gK was unable to infect corneal epithelium and establish latency in the trigeminal 
ganglia after ocular inoculation of mice. In the above mentioned investigation, we have 
observed that lack of the amino terminus of gK is associated with lack of ocular disease in 
infected mice. Further investigation of this observation (still in progress) revealed a potential 
role for gK in the immunopathogenesis of keratitis. The research work presented in this 
xi 
 
dissertation is of paramount importance as it identifies gK as an important neurotropic 
determinant, and it delineates gK domains responsible for neuroinvasion and 
immunopathogenesis in vivo. This work may lead to the development of replication competent, 
safe vaccine vectors, and paves the way for the discovery of new therapeutics for herpes 
keratitis. 
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CHAPTER I: INTRODUCTION 
Statement of Problem and Hypothesis 
Herpes simplex virus type 1 causes multiple medical disorders such as oral lesions, 
keratitis, encephalitis and systemic disease. A characteristic feature of the HSV-1 life cycle is 
infection of sensory neurons, where the virus establishes a latent infection in the trigeminal 
ganglia. The infection starts at the mucocutaneous areas (site of exposure) followed by entry 
into the axonal termini of sensory neurons. The virus recruits cellular transport machinery to 
translocate in retrograde manner to the body of the neuron. In the neuronal cell body, the virus 
remains latent for the life of the host. Although not completely understood, exposure to ultra 
violet (UV) light or immunosuppression leads to bouts of reactivation whereby the virus 
transports in anterograde manner to the primary site of infection. HSV-1 is the leading cause of 
infectious blindness in the developed world; there is an estimated 400,000 people suffer from 
herpes ocular disease in the United States. Recurrent herpes keratitis leads to corneal opacity 
and vision loss. Also, reactivation of latent virus from the trigeminal ganglia (TG) can cause 
spread to corneal transplants causing corneal graft failure.  
Herpes viruses consist of a dense double stranded DNA core enclosed in an icosahedral 
capsid. The capsid is surrounded by proteinaceous tegument and an envelope derived from 
cellular membranes. The envelope contains 12 glycoproteins that function in multiple aspects 
of viral life cycle, and virus-host interactions. The virus uses a core fusion complex composed of; 
gB, gH/gL, and gD, and the accessory proteins gK and UL20p for optimal fusion. gB and gH/gL 
are conserved among all Herpesviruses. Although not conserved, gD has functional homologues 
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in all herpesviruses. gK is conserved among alphaherpesviruses (neurotropic viruses). The 
envelope protein gK is involved in virion egress, envelopment, and viral fusion and syncytia 
formation. Viral glycoproteins gK, gM, gE and the membrane protein UL11 have been shown to 
be important for virus assembly, egress and virus spread. Research in this laboratory has 
uncovered an important role for gK in neuroinvasion. However, the recombinant gK null viruses 
that were constructed previously to study gK function exhibited major defects in replication and 
cell to cell spread in tissue culture, which are considered unfavorable qualities for vaccine 
vector development. The hypothesis promulgated in this dissertation is that a functional 
hierarchy among viral membrane proteins exists with respect to their importance in viral life 
cycle and virus-host interaction in vivo.  We also hypothesize that gK structure can be divided 
into functional domains each of which confers distinct characteristics on virus properties. The 
hypothesis predicts that the amino terminus of gK, which contains two N-glycosylation sites, is 
necessary for viral neurtropism and the fusion process during virion entry as well as for 
immunopathogenesis.  
Statement of Research Objectives 
The first goal of this research was to explore the relative functional importance of a 
subset of viral membrane proteins in their role in ocular pathogenesis and establishment of 
latency in ganglionic neurons. The second goal was to assess the role of the amino terminus of 
gK in neuroinvasion and immunopathogenesis of keratitis as well as virus replication and 
spread.  
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The specific aims of this research include: 
I. To investigate the relative importance of each of gK, gM, gE and the membrane protein 
UL11 in infection of ganglionic neurons following ocular inoculation of mice. 
a. To fully characterize the constructed recombinant viruses that lack the 
expression of either gK, gM, gE or the membrane protein UL11 in tissue culture 
by analyzing viral growth kinetics and plaque morphology. 
b. To assess whether the lack of either gE, gM, gK or UL11 affects the clinical ocular 
disease development and viral shedding. 
c. To determine whether gK-null, gE-null, gM-null, and UL11-null viruses infect 
ganglionic neurons and establish latency. 
II. To delineate the role of the amino terminus of gK in neuro-invasion and pathogenesis of 
herpes keratitis. 
a. To construct recombinant herpes simplex virus type one on a McKrae 
background lacking the amino terminus of gK using a two-step Red 
recombination Bacterial Artificial Chromosome mutagenesis system.  
b. To fully characterize the newly constructed viruses in tissue culture by analyzing 
viral growth kinetics and plaque morphology. 
c. To assess the role of the amino-terminus of gK in neuroinvasion and ocular 
pathogenesis in a scarified cornea mouse model (in vivo). 
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d. To monitor ocular clinical disease progression and score the severity of ocular 
disease. 
e. To determine whether viral DNA genomes of the recombinant virus lacking the 
amino terminus of gK and the wild type virus, can be detected in the trigeminal 
ganglia. 
f. To determine if infectious virions can be recovered from ganglionic neurons after 
ocular inoculation of mice. 
g. To further investigate the role of the amino terminus of gK in the pathogenesis 
of keratitis. 
Overall, the results obtained from this work indicate that: 
I. Glycoprotein K plays the most important role among gM, gE, and UL11 in infection of 
ganglionic neurons and establishment of latency. 
II. The mutant viruses lacking either gE, gM, gK or UL11, did not cause significant clinical 
ocular symptoms and had reduced viral shedding titers than the wild type virus.   
III. The wild type virus and recombinant HSV-1 viruses lacking either gE, gM, or UL11 were 
able to infect ganglionic neurons and establish latency. However, gK-null virus was 
unable to infect axonal termini and establish latency in the body of ganglionic neurons.  
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IV. UL11-null virus replicated in mouse eyes and Vero cell monolayers less efficiently than 
gM-null and gE null mutants; however, it infected ganglionic neurons and established 
latency more efficiently than either the gM or gE-null viruses. 
V. A recombinant herpes virus type 1 lacking the amino terminus of gK replicates efficiently 
in tissue culture; however, consistently produced significantly smaller plaques than the 
parental virus. Therefore the amino terminus of gK is dispensable for replication in 
tissue culture but important for cell to cell spread in vitro.  
VI. HSV-1 McKrae wild type virus causes severe keratitis, conjunctivitis and blepharitis 
whereas a virus lacking the amino terminus of gK did not cause significant ocular 
changes. 
VII. The virus lacking the amino terminus of gK was unable to infect axonal termini and 
establish latency in the trigeminal ganglia after ocular inoculation. This result suggests 
that the amino terminus portion of gk is the domain responsible for its function in 
neuroinvasion. 
The work presented here is placed into individual chapters in a manuscript format with chapter 
titles reflecting the central theme of the research contained therein. 
Chapter III: Functional hierarchy of herpes simplex virus type-1 membrane proteins in 
corneal infection and virus transmission to ganglionic neurons. 
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Chapter IV: A replication competent HSV-1(McKrae) with a mutation in the amino-
terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea 
infection. 
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CHAPTER II: LITERATURE REVIEW 
History of Herpesviruses 
Herpesviruses are ancient pathogens co-evolved with their hosts for millions of years 
(Kolb et al., 2013). Due to this long herpesvirus-host relationship, phylogenetic analysis of 
Herpesviruses have been used recently as a surrogate biomarker to study human population 
structure and past migration patterns throughout history (Kolb et al., 2013) (McGeoch et al., 
2000). The earliest accounts that describe herpes virus infections date back to a Sumerian 
tablet approximately 3000 BCE and in the Ebers Papyrus circa 1500 BC (Roizman et al., 2007; 
Roizman and Whitley, 2001). The Greek word “Herpes” or Herpin was used by Hippocrates to 
describe the skin lesions that creep or crawl. However at that time, herpes was applied to many 
different skin ailments (Roizman et al., 2007; Wildy, 1973).  
In the 18th century, the French physician John Astruc, in his capacity as a physician for 
King Louis XIV, was the first to describe herpes genitalis by studying skin afflictions of French 
prostitutes. He published his description of genital herpes in his book De Morbis Venereis in 
1736 (Roizman et al., 2007). In 1883, Paul Gerson Unna described herpes skin lesions as a 
“vocational disease” of women and also provided descriptions for the recurrences of genital 
lesions (Roizman et al., 2007; Roizman and Whitley, 2001). Shortly after that; Les Herpes 
Denitaux, the first book specifically devoted to herpes, was published by Charles-Paul Diday and 
Adrien Doyon in 1886.  
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A decade later, Jean Alfred Fournier wrote about the diagnosis, treatment and 
prevention of genital herpes infections; his recommendations were to abstain from alcohol, 
tobacco and “sexual excesses”. Evidence for the contagious nature of herpes infections was 
provided by the French dermatologist Jean Baptiste Émile Vidal as he showed that vesicular 
lesions can be transmitted form one patient to another, and from one anatomical location to 
another in the same individual. Vidal used human volunteers in his experiments. Wilhelm 
Grüter however, used rabbits as animal models to demonstrate that HSV serially transmitted 
between rabbits. Grüter is credited by the virology community for the isolation of HSV (Gruter, 
1924; Roizman et al., 2007).    
HSV has been recognized as an infectious agent in the late 1800s; however, the 
connection between HSV and recurrent infections was not established until 1930s. Andrews 
and Carmichael have made the observation that recurrent infections occurred only in adults 
who have been previously infected with the virus evidenced by the presence of neutralizing 
antibodies (Roizman et al., 2007; Roizman and Whitley, 2001). Burnet and Williams articulated 
the modern view on latency in 1939; the virus remains latent after infection, and stimuli such as 
trauma or fever, provoke reactivation and visible herpetic lesions (Burnet, 1939). In 1971 and 
over 40 years after Grüter’s original isolation of HSV, Schneweis and Nahmias demonstrated the 
existence of two separate serotypes of HSV and their association with either orolabial herpes 
(HSV-1) or genital herpes (HSV-2)(Roizman et al., 2007; Schneweis and Nahmias, 1971). The 
discovery of Acyclovir in the 1980’s dramatically increased the public awareness for genital  
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herpes; however, the stigmatization of the condition was overshadowed by the arrival of the 
human immunodeficiency virus and the public concerns of a global HIV epidemic (Cuatrecasas, 
2006; Kimberlin, 2014).  
During the first half of the 20th century, advancements in tissue culture techniques and 
virus isolation methods have enabled us to isolate and identify viruses with relative ease. 
Varicella-zoster virus (VZV) and human cytomegalovirus (CMV) were isolated in the 1950s, and 
the developments in the cultivation of B lymphocytes resulted in the discovery of Epstein-Barr 
virus (EBV) in 1964 (Craig et al., 1957; Epstein et al., 1964; Weller and Stoddard, 1952). 
Developments in T lymphocytes cell culture techniques allowed for the isolation and 
identification of Human Herpesviruses 6A, 6B and 7 in the late 1980s (Frenkel et al., 1990; 
Lopez et al., 1988; Salahuddin et al., 1986). Kaposi’s sarcoma-associated herpesvirus (KSHV) or 
human herpesvirus 8 (HHV-8) was discovered in 1994 using representational difference analysis 
(RDA). This novel technique –at that time- was utilized to identify sequence differences 
between two complex genomes (Chang et al., 1994).  
The rapid advances in molecular biology and sequencing technologies in the last decade 
will undoubtedly revolutionize our understanding of the inner working of known viruses and 
facilitate the discovery of a plethora of new viruses (Hall, 2007).  
Taxonomy of Herpesviruses 
Taxonomy is the science of systematic classification of biological organisms into Taxa, or 
groups, based on shared characteristics (Davison, 2010; Fenner, 1976). Biological organisms are 
classified so that hierarchical level “domain” is the most inclusive taxonomic rank, whereas 
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virus classification system employs the hierarchical levels of Order, Family, Subfamily, Genus, 
and Species. Classification of viruses is managed and standardized by the committee of the 
Virology Division of the International Union of Microbiological Societies known as International 
Committee on Taxonomy of Viruses (ICTV). ICTV has produced nine reports published in 
intervals since it was established in 1971. These reports contain developments in virus 
taxonomy (Davison, 2010). In early days, classification of viruses was based on host range and 
broad pathogenic and epidemiological features, however, technological advances in molecular 
biology and tissue culture as well as the growing use of electron microscopy and 
physicochemical methods enabled more accurate viral identification and classification.  The 
development of specific antibodies enabled the study of antigenic relationships and allowed 
researchers to differentiate between closely related viruses (Davison, 2010). Advances in 
nucleic acid sequencing and the broad utility of this approach enhanced our ability to 
differentiate between closely related species at higher resolution and rationalized taxonomy; 
which eventually lead to the adoption of sequence-based phylogenetic analysis as the key 
determinant for classification of living organisms (Davison, 2010).  
The genus herpesvirus was established in the first ICTV report in 1971 (International 
Committee on Nomenclature of Viruses. and Wildy, 1971). The genus consisted of 4 groups and 
23 viruses. In the second ICTV report in 1976, Herpesvirus genus was elevated to the family 
Herpetoviridae. The second report also added Human herpesvirus 2 as a close relative of 
Human herpesvirus 1 to the genus Herpesvirus. To avoid the misleading association of this 
family name with reptiles, ICTV renamed Herpetoviridae to Herpesviridae in the third report in 
1979. The third ICTV report also subdivided the Herpesviridae family into three subfamilies; 
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Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae(Matthews, 1979). In the ICTV 
release in 2008, a new order, Herpesvirales, was introduced and the family Herpesviridae and 
the new families Alloherpesviridae and Malacoherpesviridae were created (Davison, 2010; 
Davison et al., 2009). Herpesviridae includes viruses of mammals, birds and reptiles, and the 
family Alloherpesviridae encompasses viruses that infect fish and frogs, while the family 
Malacoherpesviridae incorporates viruses that infect molluscs (Davison et al., 2009).  
Members of Alphaherpesvirinae subfamily share several common characteristics; ability 
to infect neuronal cells and establish latency in cell bodies, variable host range, efficient lytic 
phase of infection in epithelial cells and other non-neuronal cells, relatively short replication 
cycle and efficient cell to cell spread. Members of Betaherpesvirinae share several common 
characteristics; establish latency in secretory glands, lymphoreticular cells and kidneys, a slow 
life cycle, restricted host range and cytomegaly (enlarged infected cells). Members of 
Gamaherpesvirinae have several common features which include; they maintain latency in 
lymphoid tissue, infect a limited host range, replicate in lymphoblastoid cells in tissue culture, 
some members has a lytic replication in epithelial cells and fibroblasts (Roizman et al., 2007). 
The most recent online version of the official ICTV taxonomy released in 2013 
recognizes a total of 2827 viral species, while the order Herpesvirales currently is home for 3 
families, 3 subfamilies, 19 genera and 102 species (table 2-1). 
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Table 2.1: Classification of herpesviruses. Adapted with permission from PhD dissertation titled 
“The Role of Viral Glycoproteins and Tegument Proteins in Herpes Simplex Virus Type 1 
Cytoplasmic Virion Envelopment” by Dmitry V. Chouljenko, Louisiana State University, School of 
Veterinary Medicine, Department of Pathobiological Sciences, August 2014. This table was 
originally adapted with permission from [Veterinary Microbiology 143(1-2): 52-69, Herpesvirus 
systematics]. Copyright (2010) Elsevier. Table has been updated with data from the 2013 ICTV 
virus taxonomy release available at ictvonline.org. Asterisks indicate the type species in each 
genus. 
 
Taxon name  Common name  Acronym  
Order Herpesvirales  
 
Family Alloherpesviridae  
Genus Batrachovirus  
       Ranid herpesvirus 1* Lucké tumor herpesvirus  RaHV1  
       Ranid herpesvirus 2  Frog virus 4  RaHV2  
Genus Cyprinivirus  
       Anguillid herpesvirus 1  Eel herpesvirus  AngHV1  
       Cyprinid herpesvirus 1  Carp pox herpesvirus  CyHV1  
       Cyprinid herpesvirus 2  Goldfish haematopoietic necrosis virus  CyHV2  
       Cyprinid herpesvirus 3*  Koi herpesvirus  CyHV3  
Genus Ictalurivirus  
       Ictalurid herpesvirus 1*  Channel catfish virus  IcHV1  
       Ictalurid herpesvirus 2  Black bullhead herpesvirus  IcHV2  
       Acipenserid herpesvirus 2  White sturgeon herpesvirus 2  AciHV2  
Genus Salmonivirus  
       Salmonid herpesvirus 1*  Herpesvirus salmonis  SalHV1  
       Salmonid herpesvirus 2  Oncorhynchus masou herpesvirus  SalHV2  
       Salmonid herpesvirus 3  Epizootic epitheliotropic disease virus  SalHV3  
 
Family Herpesviridae  
Subfamily Alphaherpesvirinae  
Genus Iltovirus  
       Gallid herpesvirus 1*  Infectious laryngotracheitis virus  GaHV1  
       Psittacid herpesvirus 1  Pacheco's disease virus  PsHV1  
Genus Mardivirus  
       Anatid herpesvirus 1  Duck enteritis virus  AnHV1  
       Columbid herpesvirus 1  Pigeon herpesvirus  CoHV1  
       Gallid herpesvirus 2*  Marek's disease virus type 1  GaHV2  
       Gallid herpesvirus 3  Marek's disease virus type 2  GaHV3  
       Meleagrid herpesvirus 1  Turkey herpesvirus  MeHV1  
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(Table 2.1 continued)   
Taxon name  Common name  Acronym  
Genus Scutavirus  
       Chelonid herpesvirus 5*  Chelonid fibropapilloma-associated 
herpesvirus  
ChHV5  
Genus Simplexvirus  
       Ateline herpesvirus 1  Spider monkey herpesvirus  AtHV1  
       Bovine herpesvirus 2  Bovine mammillitis virus  BoHV2  
       Cercopithecine herpesvirus 2  Simian agent 8  CeHV2  
       Human herpesvirus 1*  Herpes simplex virus type 1  HHV1  
       Human herpesvirus 2  Herpes simplex virus type 2  HHV2  
       Leporid herpesvirus 4  Leporid herpesvirus 4  LeHV4  
       Macacine herpesvirus 1  B virus  McHV1  
       Macropodid herpesvirus 1  Parma wallaby herpesvirus  MaHV1  
       Macropodid herpesvirus 2  Dorcopsis wallaby herpesvirus  MaHV2  
       Papiine herpesvirus 2  Herpesvirus papio 2  PaHV2  
       Saimiriine herpesvirus 1  Marmoset herpesvirus  SaHV1  
Genus Varicellovirus  
       Bovine herpesvirus 1  Infectious bovine rhinotracheitis virus  BoHV1  
       Bovine herpesvirus 5  Bovine encephalitis herpesvirus  BoHV5  
       Bubaline herpesvirus 1  Water buffalo herpesvirus  BuHV1  
       Canid herpesvirus 1  Canine herpesvirus  CaHV1  
       Caprine herpesvirus 1  Goat herpesvirus  CpHV1  
       Cercopithecine herpesvirus 9  Simian varicella virus  CeHV9  
       Cervid herpesvirus 1  Red deer herpesvirus  CvHV1  
       Cervid herpesvirus 2  Reindeer herpesvirus  CvHV2  
       Equid herpesvirus 1  Equine abortion virus  EHV1  
       Equid herpesvirus 3  Equine coital exanthema virus  EHV3  
       Equid herpesvirus 4  Equine rhinopneumonitis virus  EHV4  
       Equid herpesvirus 8  Asinine herpesvirus 3  EHV8  
       Equid herpesvirus 9  Gazelle herpesvirus  EHV9  
       Felid herpesvirus 1  Feline herpesvirus 1  FHV1  
       Human herpesvirus 3*  Varicella-zoster virus  HHV3  
       Phocid herpesvirus 1  Harbour seal herpesvirus  PhoHV1  
       Suid herpesvirus 1  Pseudorabies virus  SuHV1  
Unassigned species in the subfamily  
       Chelonid herpesvirus 6  Lung-eye-trachea disease-associated 
virus  
ChHV6  
Subfamily Betaherpesvirinae  
Genus Cytomegalovirus  
       Aotine herpesvirus 1  Herpesvirus aotus type 1  AoHV1  
       Cebine herpesvirus 1  Capuchin herpesvirus AL-5  CbHV1  
       Cercopithecine herpesvirus 5  Simian cytomegalovirus  CeHV5  
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(Table 2.1 continued)   
Taxon name  Common name  Acronym  
       Human herpesvirus 5*  Human cytomegalovirus  HHV5  
       Macacine herpesvirus 3  Rhesus cytomegalovirus  McHV3  
       Panine herpesvirus 2  Chimpanzee cytomegalovirus  PnHV2  
       Papiine herpesvirus 3  Baboon cytomegalovirus  PaHV3  
       Saimiriine herpesvirus 4  Squirrel monkey cytomegalovirus  SaHV4  
Genus Muromegalovirus  
       Murid herpesvirus 1*  Murine cytomegalovirus  MuHV1  
       Murid herpesvirus 2  Rat cytomegalovirus  MuHV2  
       Murid herpesvirus 8  English rat cytomegalovirus  MuHV8  
Genus Probiscivirus  
       Elephantid herpesvirus 1*  Elephant endotheliotropic herpesvirus  ElHV1  
Genus Roseolovirus  
       Human herpesvirus 6A*  Human herpesvirus 6A  HHV6A  
       Human herpesvirus 6B  Human herpesvirus 6B  HHV6B  
       Human herpesvirus 7  Human herpesvirus 7  HHV7  
Unassigned species in the subfamily  
       Caviid herpesvirus 2  Guinea pig cytomegalovirus  CavHV2  
       Suid herpesvirus 2  Pig cytomegalovirus  SuHV2  
       Tupaiid herpesvirus 1  Tupaiid herpesvirus  TuHV1  
Subfamily Gammaherpesvirinae  
Genus Lymphocryptovirus  
       Callitrichine herpesvirus 3  Marmoset lymphocryptovirus  CalHV3  
       Cercopithecine herpesvirus 14  African green monkey EBV-like virus  CeHV14  
       Gorilline herpesvirus 1  Gorilla herpesvirus  GoHV1  
       Human herpesvirus 4*  Epstein–Barr virus  HHV4  
       Macacine herpesvirus 4  Rhesus lymphocryptovirus  McHV4  
       Panine herpesvirus 1  Herpesvirus pan  PnHV1  
       Papiine herpesvirus 1  Herpesvirus papio  PaHV1  
       Pongine herpesvirus 2  Orangutan herpesvirus  PoHV2  
Genus Macavirus 
       Alcelaphine herpesvirus 1*  Wildebeest-associated malignant 
catarrhal fever virus  
AlHV1  
       Alcelaphine herpesvirus 2 Hartebeest malignant catarrhal fever 
virus  
AlHV2 
       Bovine herpesvirus 6 Bovine lymphotropic herpesvirus  BoHV6  
       Caprine herpesvirus 2 Caprine herpesvirus 2 CpHV2  
       Hippotragine herpesvirus 1  Roan antelope herpesvirus  HiHV1  
       Ovine herpesvirus 2  Sheep-associated malignant catarrhal 
fever virus  
OvHV2  
       Suid herpesvirus 3  Porcine lymphotropic herpesvirus 1  SuHV3  
       Suid herpesvirus 4  Porcine lymphotropic herpesvirus 2  SuHV4  
       Suid herpesvirus 5  Porcine lymphotropic herpesvirus 3  SuHV5  
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(Table 2.1 continued)   
Taxon name  Common name  Acronym  
Genus Percavirus 
       Equid herpesvirus 2*  Equine herpesvirus 2  EHV2  
       Equid herpesvirus 5  Equine herpesvirus 5  EHV5  
       Mustelid herpesvirus 1  Badger herpesvirus  MusHV1  
Genus Rhadinovirus  
        Ateline herpesvirus 2 Herpesvirus ateles strain 810  AtHV2  
        Ateline herpesvirus 3  Herpesvirus ateles  AtHV3  
       Bovine herpesvirus 4  Bovine herpesvirus 4  BoHV4  
       Cricetid herpesvirus 2  Pygmy rice rat herpesvirus  CrHV2  
       Human herpesvirus 8  Kaposi’s sarcoma-associated 
herpesvirus  
HHV8  
       Macacine herpesvirus 5  Rhesus rhadinovirus  McHV5  
       Murid herpesvirus 4  Murine herpesvirus 68  MuHV4  
       Murid herpesvirus 7  Wood mouse herpesvirus  MuHV7  
       Saimiriine herpesvirus 2*  Herpesvirus saimiri  SaHV2  
Unassigned species in the subfamily  
       Equid herpesvirus 7  Asinine herpesvirus 2  EHV7  
       Phocid herpesvirus 2  Phocid herpesvirus 2  PhoHV2  
       Saguinine herpesvirus 1  Herpesvirus saguinus  SgHV1  
Unassigned species in the family  
       Iguanid herpesvirus 2  Iguana herpesvirus  IgHV2  
Family Malacoherpesviridae  
Genus Aurivirus  
       Haliotid herpesvirus 1*  Abalone herpesvirus  AbHV1  
Genus Ostreavirus  
       Ostreid herpesvirus 1*  Oyster herpesvirus  OsHV1  
   
 
A definition of a virus species was first created by van Regenmortel in 1989. He defined 
a virus species as “a polythetic class of viruses that constitute a replicating lineage and occupy a  
particular ecological niche”.  The ICTV adopted this definition in 1991, and formalized for the 
first time the concept of virus species in its 7th report. A formal system for naming 
herpesviruses was founded before 1979 with a number of changes taking place over the 
following years. Herpesvirus nomenclature system maintained that herpesviruse species is 
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named after the taxon (family or subfamily) of its primry natural host, however, 
humanherpesviruses maintained human as a designation instead of hominid. This host-derived 
term is followed by the word herpesvirus, and an Arabic number (1973; Davison, 2010; Fenner, 
1976; Matthews, 1979; Roizman et al., 1981; Roizmann et al., 1992). Herpesviruses have been  
classified as distinct species if “(a) their nucleotide sequences differ in a readily assayable and 
distinctive manner across the entire genome and (b) they occupy different ecological niches by 
virtue of their distinct epidemiology and pathogenesis or their distinct natural hosts”(Davison, 
2010).  
Currently, as phylogenetic analysis based on sequence comparison data has 
revolutionized biology, and is being used as the basis of taxonomic classification. The ICTV 
Herpesvirales Study Group is considering updates in Herpesviruse taxonomy scheme, and to 
accommodate the need to classify the rapidly growing number of herpesviruses that have been 
detected only by polymerase chain reaction (PCR). The ICTV makes the distinction between the 
Virus and Virus species; virus refers to the “real physical entities produced by biological 
evolution and genetics”, it can be manipulated and can be further subdivided into more 
granular units such as; strains, variants and isolates. Virus species, on the other hand, refers to 
the “abstract concepts produced by rational thought and logic”.  
Structure of Herpes Virion 
A mature herpes virion ranges from 120-300 nanometer (nm) in diameter. It is 
composed of 4 distinct structural components; an electron dense core of double stranded DNA, 
a capsid shaped as convex polyhedron, a tegument layer and an envelope (Figure 2.1). 
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Figure 2.1: The Structure and morphology of herpesvirus.  A mature herpes virion ranges from 
120-300 nanometer (nm) in diameter The herpes virion is composed of a dense core containing 
double stranded DNA genome enclosed in an icosahedral nucleocapsid, the nucleocapsid is 
surrounded by a proteinaceous material called tegument which is further surrounded by a 
double-layer membrane called the envelope containing glycoproteins. (A) Schematic diagram 
for herpesvirus structure. Image from: http://www.twiv.tv/virus-structure/ (B) electron 
micrograph of a mature HSV-1 virion, bar = 100 nm (Mettenleiter et al., 2009). 
A 
B 
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Herpesvirus DNA genome in general ranges from 120 kbp to 250 kbp; Herpes simplex 
virus genome is 152 kbp long. This DNA core is organized in a toroidal shape or a circle.  The 
DNA is enclosed in a T- 16 symmetrical icosahedral capsid composed of 162 capsomeres. The 
capsid is surrounded by a proteinaceous material called the tegument which is further 
surrounded by a double layered envelope derived from cellular membranes. The envelope 
contains a dozen of glycoproteins and non-glycosylated membrane proteins.   
The interactions between the capsid, tegument and envelope proteins help bring the 
virion particle together during viral assembly and stabilize virion structure. They also facilitate 
viral protein functions in various steps of viral lifecycle. Interactions between viral envelope 
proteins and cell membrane receptors facilitate viral binding, attachment and entry in to cells, 
capsid and tegument proteins also interact with cellular transport proteins to convey the capsid 
to the nucleus. The interactions between viral proteins and cellular components help 
perpetuate the HSV-1 life cycle in uninfected cells (Mettenleiter, 2004; Roizman et al., 2007). 
HSV-1 genome: 
Herpesvirus genome is packaged inside the capsid in the shape of a tourus. This toroidal 
structure (doughnut) is approximately 50 nm high, with an outside diameter of 70 nm and an 
inside diameter of 18 nm (Nazerian, 1974). Herpes simplex virus type one has a double 
stranded DNA genome, approximately 152 kbp in length with slight variations between 
different HSV-1 isolates, and it weighs approximately 100x106 Daltons (Kieff et al., 1971).  
Cytosine + Guanine content in herpesviruses ranges from 31 % -75 % across the genome. HSV-1 
genome has a relatively high (68%) cytosine (C) + guanine (G) content. Varicillozooster, another 
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alphaherpesvirus, for example; has a 46 % genomic G+C content (Baines and Pellett, 2007; 
Roizman et al., 2007). Herpesvirus genome is arranged into a unique long (UL or UL) and unique 
short (US or US) segments, flanked by terminal repeats (TR) on each terminus. The UL and US 
segments are separated by apposed internal repeats (IR) (Figure 2.2) (Roizman et al., 2007). 
 
 
Figure 2.2: Herpesvirus genome: a schematic representation of the prototypical arrangement of 
Herpesvirus genome. It consists of Unique long (UL), and unique short (US) portions flanked by 
terminal repeats (TR) and internal repeats (IR). Modified from [mBio 10.1128/mBio.00144-12, A 
herpes simplex virus 1 (McKrae) mutant lacking the glycoprotein K gene is unable to infect via 
neuronal axons and egress from neuronal cell bodies] (David et al., 2012). 
 
The repeated sequences flanking the UL segment are approximately 9000 bp in length, 
whereas, the repeated sequences surrounding the unique short segment are shorter at 
approximately 6000-7400 bp. The repeats, terminal and internal, are able to invert to one 
another to form four isomers arranged in varying orientations. These reiterated sequences 
generally, regulate the expression of several genes (Roizman et al., 2007). ICP0 for example, is 
present in the repeats flanking the unique long segments and is one of the most conserved 
genes in the long repeated sequences. ICP4 is one of the most conserved genes in the repeated 
sequences that flank the US segments. Both genes are immediate-early genes that function in 
regulation of viral and host cell gene expression and are important for reactivation of latent 
herpes simplex viruses (Baines and Pellett, 2007; Everett, 2000; Liu et al., 2010). 
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Most of herpesvirus genes are composed of a 50-200 bp promoter region, followed by a 
TATA box and an initiation site of 20-25 bases. A 30-300 bases spacer is present between the 
TATA box and a 5’ untranslated leader sequence. This leader sequence is followed by the major 
open reading frame (ORF) which is followed by 3’ untranslated segment, 10-30 bases long, and 
a polyadenylation sequence. HSV-1 encodes approximately 90 open reading frames (ORF), the 
majority of which (over 80%) are not spliced. Herpesviruses also produce noncoding RNAs. A 
well-studied example of these non-coding RNAs is the Latency Associated Transcript (LAT). It is 
difficult to determine the exact number of encoded proteins in Herpesviruses because some 
herpesvirus genes do not have a TATA box, possess a second initiation sites and show a 
disregard of predicted transcription termination sites for several late genes; nonetheless, there 
are approximately 84 transcriptional units participating in the production of herpes simplex 
type 1 viral proteins (Davison, 2007; Mavromara-Nazos and Roizman, 1989; McGeoch et al., 
2006; Roizman et al., 2007).  
The UL region of herpesvirus genome encodes genes that tend to be more conserved 
among alphaherpesviruses than genes encoded by the US segment. Enzymes that are necessary 
for viral replication and metabolism are the most conserved and are encoded by the unique 
long segment; examples include UL5, UL15, UL30 and UL40. (Baines and Pellett, 2007; Roizman 
et al., 2007). 
A number of genes are conserved among all herpesviruses such as gB. Other genes are 
only shared by alphaherpesviruses such as gK. A few genes unique to HSV-1 and HSV-2 and not 
shared with other alphaherpesviruses also exist. Important examples are γ1 34.5 and US11; 
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they encode a 263 aa and a 161 aa proteins, respectively.  US11 is a dsRNA-binding protein; it 
antagonizes the action of double-stranded RNA-dependent protein kinase (PKR) and inhibits 
stress-induced translational arrest. γ1 34.5 has been implicated in the inhibition of autophagy  
and in the de-phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF-
2α) in order to prevent shutoff of viral protein synthesis by the action of activated PKR (He et 
al., 1997; Lussignol et al., 2013; Roizman et al., 2007).  
Unique to herpes simplex viruses, type 1 and 2, is the Latency associated transcript 
(LAT), it is a non-coding RNA transcript that accumulates in the nuclei of neurons during latent 
infection. US4 gene is unique to simplex viruses; it encodes glycoprotein G (gG) which is 
significantly smaller (~1500 bp smaller) in HSV-1 compared to HSV-2 and has been used in 
serological assays to differentiate between the two viruses. Other examples of genes unique to 
simplex virus are; the US5 gene and US8.5 gene they encode glycoprotein J (gJ) which is 
involved in preventing cytotoxic T-lymphocyte-induced apoptosis of infected cells, and a 
phosphorylated protein that tends to localize in the nucleoli of infected cells, respectively. The 
US12 gene encoding ICP47 interferes with MHC-I mediated antigen presentation in infected 
cells. US 12 is another example of genes exclusively expressed by simplex viruses (Baines and 
Pellett, 2007; Georgopoulou et al., 1995; Ghiasi et al., 1998; Jerome et al., 1999; Lee et al., 
1985; Roizman et al., 2007; York et al., 1994). 
A few of viral gene products have been labeled as “non-essential” for viral replication in 
vitro. These genes were labeled as such as experiments were performed on a single cell type or 
in a narrow context of a particular condition of an experiment. Later, some of the proteins 
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labeled as nonessential were proven to be essential in vivo and play important roles in infection 
of various host cell types, neurotropism, latency, and evasion of host immune responses 
(Nishiyama, 2004). 
HSV-1 capsid 
A mature herpesvirus genome is contained within a uniform and symmetric icosahedral 
capsid which is approximately 15 nm thick, 1250 Angstrom in diameter and weighs 200 Mega 
Dalton (MDa). The capsid is composed of 162 capsomeres that lie on a T-16 symmetrical 
icosahedral frame. Five structural proteins form the building blocks of a capsid; VP5 (UL19), 
VP26 (UL35), VP23 (UL18), VP19C (UL38), and the portal protein pUL6. These five structural 
proteins and two additional proteins, pUL25 and pUL17, make up the C-capsid specific 
components in mature DNA-filled capsids (Table 2.2). pUL26/26.5 are part of  scaffold capsid 
proteins that get lost when the DNA is packaged into the capsid. pUL26/26.5 is not present in 
mature virions (Brown and Newcomb, 2011; Newcomb et al., 1999; Zhou et al., 2000).  
Table 2.2: C-capsids structural protein composition. Adapted with modification from (Brown 
and Newcomb, 2011). 
 
 
 
 
 
 
Gene Protein Amino acids Location in capsid 
UL19 VP5 1374 Hexons; pentons 
UL38 VP19C 465 Triplexes 
UL18 VP23 318 Triplexes 
UL35 VP26 112 Tip of hexon 
UL6 pUL6 676 Unique vertex 
UL17 pUL17 703 Near vertices 
UL25 pUL25 546 Near vertices 
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The 162 capsomeres are subdivided into 150 hexons, 12 pentons and 320 triplexes 
(Figure 2.3). The hexons form the edges and faces of the icosahedral capsid; each hexon is 
composed of 6 copies of VP5 and 6 copies of VP26. Each penton has 5 copies of VP5. Pentons 
are located at capsid vertices and interact with UL36 tegument protein in mature virions. The 
capsomeres are liked by a the triplexes which are composed of are composed of two copies of 
VP23 and one copy of VP19C arranged as a heterodimer (Brown and Newcomb, 2011; Cardone 
et al., 2012; Newcomb and Brown, 2010; Schmid et al., 2012; Zhou et al., 2000). 
                               
Figure 2.3: HSV-1 capsid structure.  HSV-1 capsid with 12 pentons (red), 150 hexons (blue), and 
320 triplexes (green). Image from (Zhou et al., 2000).  
 
The capsid has 12 vertices; 11 of which are occupied by pentons. The 12th vertex is 
occupied by a hollow cylindrical portal structure, 9 nm in length and 16.5 nm in outside 
diameter with a ~3 nm diameter axial channel.  This portal vertex is structurally composed of 
twelve copies of pUL6 with 12-fold rotational symmetry. The portal vortex is thought to provide 
the route for packaging and release of viral DNA. It may also play a role in docking of capsid to 
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the nuclear pore complexes (NPCs). The portal vortex may potentially influence the spatial 
arrangement of viral tegument and envelope as it has been shown to extend through the 
tegument layer and possibly come in contact with the envelope (Brown and Newcomb, 2011; 
Meyring-Wosten et al., 2014; Schmid et al., 2012). 
Three morphologically distinct types of capsids (A, B, and C) can be observed by electron 
microscopy in infected cells. A-capsids are empty as a result of failed DNA packaging process. B-
capsids also lack viral DNA, but contain scaffolding proteins. C-capsids are the type of capsids 
that are ultimately found in mature infectious virions. They contain viral DNA and no scaffolding 
protein. Also, C-capsids are distinguished by the presence of C-capsid specific components 
(CCSCs) near capsid vertices (Figure 2.4).  
 
 
 
 
 
 
 
 
 
 
Figure 2.4: The location of C-capsid specific components (CCSCs). CCSCs are highlighted in 
green. Left panel shows a higher magnification of CCSCs in a single capsid vertex. Right, CCSCs 
location is shown in the full capsid. Adapted and modified from (Brown and Newcomb, 2011). 
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CCSCs are a rod shaped structure made up of one copy of pUL25 and one copy of pUL17. 
It has been shown that CCSCs interface with the tegument by binding to the UL36 protein. 
CCSCs is thought to fasten neighboring pentons against the internal pressure in DNA-loaded C-
capsids (Brown and Newcomb, 2011; Homa and Brown, 1997; Liu and Zhou, 2007).   
HSV-1 tegument  
The tegument is a proteinaceous matrix and a network layer that bridges the capsid and 
the envelope. The tegument in mature virions consists of 24 proteins, including pUL7, pUL11, 
pUL13, pUL14, pUL16, pUL21, pUL23, pUL36 (VP1/2), pUL37, pUL41, pUL46 (VP11/12), pUL47 
(VP13/14), pUL48 (VP16), pUL49 (VP22), pUL50, pUL51, pUL55, pUS2, pUS3, pUS10, pUS11, 
ICP34.5, ICP0 and ICP4 (Table 2.3). Four proteins, pUL46 (VP11/12), pUL47 (VP13/14), pUL48 
(VP16) and pUL49 (VP22) are present in over a 1000 copy each and constitute the majority of 
the tegument volume. By comparison, the tegument proteins pUL36 and pUL37 are present in 
~120 copies per virion (Kelly et al., 2009; Newcomb and Brown, 2009). Tegument proteins; 
pUL36 (VP1/2), pUL37, pUL48 and ICP4 are the only HSV-1 tegument proteins that are essential 
for viral growth in cell culture (Kelly et al., 2009; Roizman et al., 2007).  
Cryo-electron tomography imaging of mature HSV-1 virions shows the tegument as 
asymmetrically distributed, dense granular layer interspersed with ~40 nm long and ~ 7 nm 
wide filaments consistent with actin. At early time points in infected cells, the tegument tend to 
be uniformly distributed around the capsid (Grunewald et al., 2003). As the virion particle  
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matures over the course of approximately 40 hours, the tegument tends to congregate on one 
side of the capsid, forming a cap-like structure and pushing the capsid off center (Grunewald et 
al., 2003). 
Tegument proteins are subdivided into inner and outer tegument proteins. Inner 
tegument proteins consist of pUS3, pUL36 and pUL37 which remain associated with the capsid 
after entry into the host cell. The remaining tegument proteins are categorized as outer 
tegument proteins which detach from the capsid after entry into host cell. (Mettenleiter, 2006; 
Newcomb and Brown, 2010). 
Table 2.3: Tegument proteins and their function. Adapted and modified from (Kelly et al., 
2009).  
 
Tegument protein Predicted Mwt (kDa) Functions 
pUL7 33.1 Regulates mitochondrial function 
pUL11 10.5 Secondary envelopment 
pUL13 57.2 Protein kinase, tegument dissociation, regulates 
apoptosis and pUS3, inhibits IFN response 
pUL14 23.9 Nuclear import, regulates apoptosis, nuclear 
targeting of capsids 
pUL16 40.4 Secondary envelopment 
pUL21 57.6 Secondary envelopment, regulates microtubule 
assembly 
pUL23 41.0 Thymidine kinase, viral DNA replication 
pUL36 (VP1/2) 335.9 Capsid transport, secondary envelopment, 
release of viral DNA, deubiquitinating activity 
pUL37 120.6 Secondary envelopment, regulates viral 
transcription 
pUL41 54.9 Regulates host/viral translation and immune 
response 
pUL46 (VP11/12) 78.2 Secondary envelopment, regulates pUL48-
dependent transcription 
pUL47 (VP13/14) 73.8 Secondary envelopment, regulates pUL48-
dependent transcription 
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(Table 2.3 continued) 
Tegument protein Predicted Mwt (kDa) Functions 
pUL50 39.1 dUTPase, viral DNA replication 
pUL51 25.5 Unknown 
pUL55 20.5 Unknown 
pUS2 32.5 Unknown 
pUS3 52.8 Protein kinase, primary deenvelopment, 
tegument dissociation, regulates actin assembly 
pUS10 34.1 Unknown 
pUS11 17.8 Regulates host translation, capsid transport 
ICP34.5 26.2 Regulates host translation, viral DNA replication 
and immune response 
ICP0 78.5 Regulates viral transcription 
ICP4 132.8 Regulates viral transcription 
 
Tegument proteins play important roles not only as structural but also as functional 
proteins (Table 2.3) (Kelly et al., 2009). UL36 protein (pUL36 or VP1/2) is a 3164 amino acid 
protein encoded by the open reading frame UL36 (Roizman et al., 2007). The inner tegument 
protein pUL36 have been shown to interact with capsid proteins VP5 and pUL25 and acts as the 
link between the capsid and the outer tegument proteins (Bucks et al., 2011; Coller et al., 
2007). Also, pUL36 directly interacts with another inner tegument protein pUL37, which directly 
interacts with the envelope proteins gK and pUL20, possibly providing a scaffold for the rest of 
the tegument (Jambunathan et al., 2014; Mijatov et al., 2007; Newcomb and Brown, 2010). The 
amino terminus of pUL36 contains a 420 aa ubiquitin-specific cysteine protease; this domain 
with its active site at Cys65 deubiquitinates viral proteins to avoid degradation by the 
proteasomal pathway (Kattenhorn et al., 2005). The amino terminus of VP1/2 also contains a 
highly conserved functional nuclear localization signal (Abaitua and O'Hare, 2008). The 
ubiquitin-specific cysteine protease domain of UL36 has been shown to down regulate IFN-Beta 
production by deubiqitinating TNF receptor-associated factor 3 (TRAF3) (Wang et al., 2013).  
28 
 
pUL36 along with other inner tegument proteins (pUL37 and pUS3) also recruits the motor 
molecule dynein and its cofactor dynactin during retrograde transport (Radtke et al., 2010). 
UL36 protein plays a role in DNA packaging and release form the capsid.  
The HSV-1 UL37 gene encodes a 120.6 kD, 1123 aa protein that encompasses a variety 
of functional domains (Figure 2.5). UL37 protein is essential for viral assembly, secondary 
envelopment in the cytoplasm and regulation of viral transcription (Bucks et al., 2011; Kelly et 
al., 2009; Mettenleiter, 2002). The amino terminus of UL37 contains a self association domain 
(in the absence of UL36), and leucine-rich nuclear export signal (NES)(Bucks et al., 2011; 
Watanabe et al., 2000). The fuction of the central domain of UL37 is yet unclear. The carboxy 
terminus of UL37 contains a motif that activates NF-kB signaling by binding TNF receptor-
associated factor 6 (TRAF6). Modulation of Nf-kB activity possibly affect the transcriptional 
activation of viral intermediate early genes such as ICP0  (Amici et al., 2006; Bucks et al., 2011; 
Liu et al., 2008). The domain spanning residues 578-899 of the carboxyl terminus of UL37 have 
also been shown to interact with a cytoskeletal cross-linker called dystonin/BPAG1 which is 
involved in microtubule stabilization and transport (Pasdeloup et al., 2013). The pUL36 and 
pUL37 are highly conserved among all Herpesviruses which highlight their importance as 
structural as well as functional viral proteins (Mettenleiter, 2002).  
 
 
29 
 
 
Figure 2.5: Functional domains of the UL37 protein. Adapted with modification from 
(Jambunathan et al., 2014). 
 
US3 and UL13 proteins are versatile viral serine/threonine protein kinases. They 
contribute along with cellular kinases, to the phosphorylation of other tegument proteins prior 
to their dissociation from the capsid during entry (Asai et al., 2007; Kato et al., 2005; Kelly et al., 
2009). US3 has an anti-apoptotic activity through phosphorylation of pro-apoptotic Bcl-2 family 
members. By contrast, pUL13 has a pro-apoptotic activity (Benetti and Roizman, 2007; 
Hagglund et al., 2002; Jerome et al., 1999; Kelly et al., 2009).   
The UL41 gene encodes the 54.9 kD outer tegument protein known as virion host 
shutoff (vhs) protein. Vhs dissociates from the virion capsid during entry and functions as an 
endoribonuclease RNase A to degrade mRNA resulting in shutting down the host cell gene 
expression as well as viral protein synthesis. Viral mRNAs though, are rescued by VP16; at a 
later stage of infection pUL48 (VP16) interacts with pUL41 to inhibit pUL41 activity and 
facilitate its incorporation into virion particles. (Lam et al., 1996; Taddeo and Roizman, 2006). 
VP16, also referred to as (α-transinducing factor (α-TIF), is an outer tegument protein 
that is required for initiation of transcription of viral alpha genes such as ICP0 and ICP4 in a lytic 
infection (Campbell et al., 1984; Kelly et al., 2009; Roizman et al., 2007).  
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ICP0 protein is encoded by the RL2 gene form the reiterated sequences region. ICP0 
protein is a 775- aa promiscuous transactivator of genes (Kelly et al., 2009; Roizman et al., 
2007). It contains a RING finger domain and ubiquitin ligase E3 domain (Roizman et al., 2007). 
The expression of ICP0 protein directly depends on pUL48 as discussed above. The efficiency of 
ICP0 functions are enhanced by its interaction with ICP4. The two major functions of ICP0 are; 
to facilitate the transition from α to β viral-gene expression and to block the inhibition of viral 
gene expression by host cell interferons through its ubiquitin ligase activity (Gu and Roizman, 
2007; Harle et al., 2002).   
The tegument is an important structural and functional component of the virion 
particle. It accounts for approximately 40% of the total virion protein mass and two-thirds of 
the virion particle volume (Grunewald et al., 2003; Liu and Zhou, 2007).  
HSV-1 envelope 
The envelope is a host-derived lipid bilayer outer covering of the virus.  Herpes Simplex 
Virus envelope contains at least 12 different glycoproteins and several other non-glycosylated 
membrane-associated viral proteins. The glycoproteins include pUL1 (gL), pUL10 (gM), pUL22 
(gH), pUL27 (gB), pUL44 (gC), pUL49.5 (gN), pUL53 (gK), pUS4 (gG), pUS5 (gJ), pUS6 (gD), pUS7 
(gI) and pUS8 (gE). The non-glycosylated membrane proteins include pUL20, pUL24, pUL43,  
pUL45, pUL56 56 and pUS9 (Campadelli-Fiume and Menotti, 2007; Roizman et al., 2007). 
Although pUL34 is not present in the envelope of extracellular virions, it mediates primary 
envelopment in concert with pUL31 (Roizman et al., 2007).  
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Cryo-electron tomography of HSV envelope reveals that the envelope is approximately 5 
nm thick with 600-750 non-randomly clustered glycoprotein spikes of highly variable length, 
spacing  and morphology embedded in the viral envelope (Figure 2.6) (Grunewald et al., 2003).   
In these tomography images, the glycoprotein spikes appears to be clustered in the 
areas were the tegument is dense, in support of the documented experimental evidence of the 
interaction between HSV-1 tegument proteins and envelope glycoproteins (Grunewald et al., 
2003). It has been shown, using mutational analysis and biochemical approaches that the 
cytoplasmic portions of gB, gD and gH bind to the outer tegument protein VP16 (pUL48)(Gross 
et al., 2003; Kamen et al., 2005; Zhu and Courtney, 1994). Also, the interactions between the 
cytoplasmic tails of gD and gE and the tegument proteins pUL11 and pUL49 (VP22) have been 
demonstrated by co-immunoprecipitation experiments (Chi et al., 2005; Farnsworth et al., 
2007a; O'Regan et al., 2007). In PRV, UL49 physically interacts with the cytoplasmic domains of 
the membrane protein US9 and the carboxyl terminus of gE/gI and gM (Fuchs et al., 2002a; Lee 
et al., 2008). Most recently, the interaction between the membrane proteins gK and pUL20 and 
pUL37 have been reported using co-immunoprecipitation experiments and proximity ligation 
assays (Jambunathan et al., 2014).  
Viral membrane proteins play important roles in viral life cycle and in the interaction 
between the virus and the host. Various glycoproteins participate in virion attachment and 
entry through interacting with host cell receptors. Membrane proteins also play crucial roles 
during egress and envelopment as well as infectious virus production via interactions with the 
tegument (Roizman et al., 2007). 
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Figure 2.6: Three- dimensional tomographic reconstruction of HSV-1 virions after denoising. (A) 
Glycoprotein spikes in yellow are protruding from the membrane colored in blue. (B) Virion 
interior, the capsid is shown in light blue and the tegument “cap” (orange) inside the envelope 
(blue and yellow). pp, proximal pole; dp, distal pole. Scale bar, 100 nm. Adapted from 
(Grunewald et al., 2003). 
 
Viral membrane proteins play important roles in viral life cycle and in the interaction 
between the virus and the host. Various glycoproteins participate in virion attachment and 
entry through interacting with host cell receptors. Membrane proteins also play crucial roles 
during egress and envelopment as well as infectious virus production via interactions with the 
tegument (Roizman et al., 2007). 
Glycoprotein B. Glycoprotein B is a 904 amino acid glycosylated transmembrane 
glycoprotein encoded by the gene UL27.  gB is the most conserved component of the fusion 
machinery of herpes viruses.  The extracellular portion (ectodomain) of gB is the largest domain 
composed of 696 aa with multiple N-glycosylation sites. The crystal structure of the gB 
ectodomain reflects features similar to both class I and class II fusion proteins with a striking 
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homology to glycoprotein G from vesicular stomatitis virus (VSV G). gB possesses an alpha-
helical coil-coil core that relates it to class I fusion proteins and an extended beta hairpin with  
hydrophobic tips that relates gB to class II fusion proteins. The gB fusogenic activity is 
accomplished through a large scale conformational change of "open" and "closed" or folding 
and unfolding rearrangements of the trimetric gB complex (Figure 2.7)(Heldwein et al., 2006). 
gB is one of four glycoproteins known as the fusion complex (gD, gH, gL, and gB). The 
interactions between gD and the gH/gL heterodimer with gB presumably trigger conformational 
rearrangements in gB to initiate fusion. It has also been shown that gB binds to cellular 
receptors such as the myelin-associated glycoprotein (MAG) paired immunoglobulin-like type-2 
receptor alpha (PILR-alpha), and non-muscle myosin heavy chain IIA (NMHC-IIA) which may also 
assist in triggering the gB conformational changes necessary for fusion (Chowdhury et al., 2012; 
Connolly et al., 2011) (Arii et al., 2010), (Satoh et al., 2008; Suenaga et al., 2010). Moreover, 
accessory proteins such as gK and UL20 may also be required for optimal fusion process. It has 
been reported that the direct interaction of gB with gK and UL20 modulates gB-mediated cell 
fusion (Chouljenko et al., 2010; Foster et al., 2004; Melancon et al., 2005).  
 
34 
 
   
Figure 2.7: Schematic diagram of gB, showing conformational refolding between a “closed” (A) 
and “open” (B) state in an umbrellalike fashion. gB Domains are shown schematically in 
different colors. Adapted from (Heldwein et al., 2006). 
 
In addition to its role in virus induced cell fusion during entry, gB has been shown to 
bind to Toll Like Receptor 2 /Toll-like Receptor 6 heterodimer leading to MyD 88 mediated 
activation of NF-kB (Cai et al., 2013).  
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Glycoprotein K. gK is a 338 aa glycosylated HSV-1 envelope protein that is encoded by 
UL53 gene. gK is highly conserved among all alphaherpesviruses. The secondary structure of gK 
is composed of an amino terminus and a carboxyl terminus both located extracellularly, four 
membrane spanning domains and small cytoplasmic domains. The amino terminus of gK 
contains a 30 aa signal sequence and two N-linked glycosylation sites at residues 48 and 58 
(Figure 2.8; gK secondary structure)(Foster et al., 2003; Ramaswamy and Holland, 1992).  
 
Figure 2.8: Schematic representation of the secondary structure of gK. The 30 amino acid signal 
peptide is shown in red. The four transmembrane domains are shown in yellow.  
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Several single amino acid mutations in gK, primarily in the amino terminus, have been 
shown to cause syncytia formation in tissue culture (Pogue-Geile et al., 1984; Ruyechan et al., 
1979). gK forms a heterodimer with the non-glycosylated membrane protein UL20. The 
interaction between gK and UL20 is important for the transport of the protein complex (gK-
UL20 heterodimer) through the Golgi network (Foster et al., 2008; Melancon et al., 2007). gK 
plays a critical role in the cytoplasmic virion envelopment and infectious virus production. gK 
deletion mutants accumulate in the cytoplasm as un-enveloped virions and are unable to egress 
from infected cells (Foster and Kousoulas, 1999; Hutchinson et al., 1992; Hutchinson and 
Johnson, 1995; Jayachandra et al., 1997; Ramaswamy and Holland, 1992). The role of gK in 
virus-induced cell fusion was studied, using a variety of deletion, truncation and syncytial 
mutants of gK.  Work in Dr. Kousoulas’ laboratory demonstrated that the amino terminus of gK 
physically interacts with the amino terminus of gB and modulates gB mediated virus induced 
cell fusion (Chouljenko et al., 2009; Chouljenko et al., 2010). Also, cleavage of the amino 
terminus of HSV-1 gK significantly reduced virus entry (Jambunathan et al., 2011). The amino 
terminus of gK is also required for efficient entry into Chinese Hamster Ovary cells (CHO cells) 
expressing the gB receptor; paired immunoglobulin-like type-2 receptor alpha 
(PILRα)(Chowdhury et al., 2013). gK overexpression was correlated with the accumulation of 
large numbers of virion particles in the perinuclear space (Hutchinson and Johnson, 1995). 
Mutant viruses lacking the expression of both gB and gK or gB and UL20 accumulated capsids in 
the cytoplasm suggesting that pUL20, gK and gB do not function redundantly in the de-
envelopment process at the outer nuclear membrane (Melancon et al., 2005).  
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In addition to gK roles in; virus-induced cell fusion, envelopment and virion egress, it 
plays important roles in neuroinvasion and ocular pathogenesis (David et al., 2008; David et al., 
2012). Further experiments to delineate gK domains that are important for neuroinvasion have 
demonstrated that the amino terminus of gK, however dispensable for replication in tissue 
culture, is important for neuroinvasion and the pathogenesis of keratitis (David et al., 2012; Kim 
et al., 2014; Saied et al., 2014). It has been shown that the signal peptide of gK contains a T cell 
epitope, however, since the signal peptide is cleaved, its significance in immunomodulation is 
yet to be determined (Osorio et al., 2007). 
I collaborated with Misagh Naderi and Dr. Michal Brylinski at the Computational 
Systems Biology group, Louisiana State University to generate a predicted tertiary (folded) 
structure for gK (Figure 2.9) and UL20 protein. gK was modeled based on validated templates. 
The predicted structure showed that the transmembrane domains are alpha helices, the amino 
terminus of gK is composed of beta sheets and short alpha helices, and domain II folds into two 
connected alpha helices. The predicted folding of domain II into alpha helices suggests that this 
domain may have an important function, which is open for investigation. The gK tertiary 
structure prediction is still in progress as we are still addressing some important factors that, if 
considered in the model, may alter the predicted tertiary structure of gK.  
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Figure 2.9: The predicted tertiary structure of gK. The amino terminus in blue (dark and light), 
the last transmembrane domain and the carboxyl terminus are in red. Domain III is predicted to 
have two connected alpha helices.  
 
Glycoprotein M. Glycoprotein M (gM) is a 473 aa, highly conserved type III integral 
membrane protein encoded by UL10 gene. gM forms a functional complex with pUL49.5 (gN). 
The structure of gM (Figure 2.10) is composed of amino terminus cytoplasmic domain that 
contains 2 initiation codons, 8 membrane spanning domains, 2 N-glycosylation sites in 
extracellular domains, and a carboxyl terminal cytoplasmic domain that contains 4 tyrosine-
based endocytosis motifs (YXXΦ; YDEV426, YAKI438, YDTV454 and YSTV470)(Baines and 
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Roizman, 1993; Crump et al., 2004; Roizman et al., 2007). Deletion UL10 gene does not abolish 
HSV-1 replication, but reduces the ability of the virus to spread from cell to cell in tissue culture 
(Browne et al., 2004; Chouljenko et al., 2012; Leege et al., 2009; MacLean et al., 1993). 
Glycoprotein M mutant viruses showed alterations in several viral membrane proteins 
localization patterns in the trans-Golgi network (TGN); which implies that gM may function in 
retention or retrieval of viral glycoproteins in or form the trans-Golgi network (TGN)(Crump et 
al., 2004; Klupp et al., 2000; Leege et al., 2009).  
The syncytial phenotype caused by mutation in the carboxyl terminus of gB [A855V 
(gBsyn) and gBΔ28] was inhibited by deletion of gM in these syncytia-forming viruses. Also, 
recombinant viruses lacking gM had slower entry kinetics in Vero cells (Balan et al., 1994; Davis-
Poynter et al., 1994; Kim et al., 2013). Work in this laboratory showed that deletion of gM and 
the membrane protein UL11 affected membrane fusion events. Two-way co-
immunoprecipitation experiments have detected an interaction between gM and UL20 (Kim et 
al., 2013). 
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Figure 2.10: A schematic diagram of the predicted secondary structure of HSV-1 gM. The yellow 
box indicates plasma membrane. Two initiation methionines (empty arrows) and two potential 
N-glycosylation sites (black solid arrows), C-terminal tyrosine-based endocytosis motifs are 
indicated by blue boxes. The dark and light green boxes indicate alpha helices. [Structure built 
by SOSUI prediction (Hirokawa et al., 1998)]. 
 
 
UL 20 protein (pUL20). UL20 protein is 222 aa non-glycosylated membrane protein that 
is conserved in all alphaherpesviruses. The predicted secondary structure of pUL20 is composed 
of five domains; the amino terminus (Domain I) and the carboxyl terminus (Domain V) are 
located within the cytoplasm, 4 transmembrane domains and Domains II and IV located 
extracellularly (Figure 2.11).  
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Figure 2.11: The predicted secondary structure of the UL20 protein. The protein is composed of 
four transmembrane domains and five predicted regions are shown. Adapted with permission 
from PhD dissertation titled “The Role of Viral Glycoproteins and Tegument Proteins in Herpes 
Simplex Virus Type 1 Cytoplasmic Virion Envelopment” by Dmitry V. Chouljenko, Louisiana State 
University, School of Veterinary Medicine, Department of Pathobiological Sciences, August 
2014. 
 
pUL20 forms a heterodimer with gK.  The interaction between gK and UL20 is important 
for the transport of the protein complex (gK-UL20 heterodimer) through the golgi network 
(Foster et al., 2008; Melancon et al., 2007). This gK/pUL20 complex functions in virion 
envelopment, egress, and virus-induced cell fusion. pUL20 functional domains play 
independent roles in virus-induced cell fusion and cytoplasmic virion envelopment; mutations 
in tyrosine residues in the amino terminus of pUL20 compromised infectious virus production 
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and virus induced cell fusion, however, allowed efficient intracellular transport and TGN 
localization of UL20p and gK (Melancon et al., 2004; Melancon et al., 2007). Most recently, 
work in this laboratory showed that phenylalanine residues at the carboxyl terminus of pUL20 
play crucial roles in viral cytoplasmic envelopment and infectious virion production. 
Interestingly, replacement of phenylalanine-to-alanine at amino acid position 210 in the 
carboxyl terminus of pUL20 caused a gain-of-function phenotype (Charles et al., 2014). 
Life Cycle of Herpes Simplex Virus Type 1 
Infection with HSV-1 starts at the mucocutaneous membranes where the virus 
replicates and then infects axonal endings and transports in retrograde manner to the body of 
the neuron in the trigeminal ganglia to establish latent infection. Exposure to UV light or 
stressors leads to reactivation of the virus whereby virions transport in anterograde manner to 
the primary site of infection for lytic replication and viral shedding.  
Infection of epithelial cells at the primary site of infection is a multistep involving virus 
entry, transport of capsids to the nucleus, viral gene expression and DNA replication, capsid 
assembly, primary envelopment, secondary envelopment, and egress and maturation of 
infectious virions. During entry, viral glycoproteins interact with cell surface receptors for the 
attachment, binding and fusion between viral envelope and the cell membrane. After entry, the 
virus sheds the envelope at the surface and the capsid and the associated inner tegument 
proteins travel to the nucleus, dock at the nuclear pore complex and deposit viral DNA to the 
nucleus leading to the start of another viral replication cycle. In the nucleus of neurons,  
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however, the virus establishes latency for the life of the host. During latency, viral DNA 
associates with nucleosomes in a circular episome form, and the Latency Associated Transcript 
(LAT) is produced. Assembly of capsids and packaging of DNA take place in the nucleus.  
In a process called primary envelopment, nucleocapsids travel to the cytoplasm by 
moving across the nuclear membrane. In the cytoplasm, tegument proteins are assembled on 
the nucleocapsid. The interaction between tegument proteins and viral envelope protein-
enriched TGN-derived vesicles facilitates acquiring the envelope in a process known as 
secondary envelopment.  Enveloped virions enclosed inside the vesicles transport to plasma 
membrane to release virions into the extracellular environment (Figure 2.12) (Bastian et al., 
1972; Roizman et al., 2007; Vittone et al., 2005).  
Viral attachment, binding and entry 
Mature infectious virion particles initiate the infection by virion attachment to the 
cellular receptors. This attachment step is mediated by binding of the amino terminus 
glycoprotein C (gC) to cell surface receptors such as heparan sulfate and chondroitin sulfate 
glycosaminoglycans (GAGs)(Campadelli-Fiume and Menotti, 2007; Herold et al., 1991; Roizman 
et al., 2007; Tal-Singer et al., 1995; WuDunn and Spear, 1989). It has also been shown that gB 
participates in the attachment step by binding to GAGs on cell surfaces(Laquerre et al., 1998). 
The ability of gB to mediate the attachment may explain the observation that deletion of gC 
does not impair viral attachment(Griffiths et al., 1998). Interestingly, deletion of heparan  
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sulfate and chondroitin sulfate glycosaminoglycans (GAGs) significantly reduces viral infectivity 
but does not completely abolish infection from taking place (Gruenheid et al., 1993). The 
attachment step is revisable and does not require energy(Campadelli-Fiume and Menotti, 
2007).            
 
Figure 2.12: Schematic diagram of Alphaherpesviruses life cycle. Electron micrographs of the 
respective stages are shown. (1) Attachment. (2) Penetration. (3) Transport of the capsid to the 
nucleus (N). (4) Interaction of nucleocapsid with microtubules (MT). (5) Docking at the nuclear 
pore (NP). (6) Release of viral genome into the nucleus. Here, transcription of viral genes and 
genome replication takes place.  (7) Assembly of Capsids. (8) Encapsidation of viral genome into 
preformed capsids. (9) Newly formed nucleocapsids leave the nucleus by budding at the Inner 
Nuclear Membrane (INM). (10) Virions located in the perinuclear space fuse (11) with the outer 
nuclear membrane. (12) Intracytosolic capsids bud into vesicles of the Trans-Golgi Network 
(TGN) in a step called secondary envelopment. After transport to the cell surface (13), (14) 
vesicle and plasma fuse to release mature virions to the extracellular space. Adapted from 
(Mettenleiter et al., 2009). 
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Typically, herpes simplex viruses enter cells via fusion of the viral envelope with plasma 
membranes; however, it can enter a wide range of cells via either pH independent or pH-
dependent endocytosis (Milne et al., 2005; Nicola et al., 2003). The entry step is mainly 
mediated by the interaction between the ectodomain of Glycoprotein D (gD) with cellular 
receptors. The transmembrane and cytoplasmic domains of gD do not seem to play a role in 
viral entry, however, they serve to anchor gD to the viral envelope (Browne et al., 2003).  
Cellular receptors for gD include members of tumor necrosis factor receptor family 
(TNF) such as herpes virus entry mediator A (HVEM or HveA). This family of cellular receptors is 
expressed on many mammalian epithelial cells, fibroblasts as well as cells of the immune 
system such as B and T lymphocytes and monocytes, however, neurons do not express this 
family of receptors (Kwon et al., 1997; Spear, 2004).   Members of immunoglobulin superfamily 
also serve as receptors for gD; examples include nectin-1, nectin-2, paired immunoglobulin-like 
type 2 receptor alpha (PILR-2 alpha) and 3-O sulfated heparan sulfates. Nectin 1 alpha and beta 
are expressed on neuronal cells as wells as epithelial cells fibroblasts and hematopoietic cells 
(Cocchi et al., 1998a; Cocchi et al., 1998b; Geraghty et al., 1998). Binding of gD to its cognate 
receptor triggers conformational changes in gB, gH, and gL which leads to the fusion of viral 
envelope with cell membrane (Campadelli-Fiume and Menotti, 2007; Cocchi et al., 2004; 
Roizman et al., 2007). 3-O-sulfated heparan sulfate is expressed in neurons as well as a variety 
of other tissues and serves as a receptor for the ectodomain of gD(Campadelli-Fiume and 
Menotti, 2007). 
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Fusion activity in HSV is executed by a multipartite fusion complex composed of gB and 
the gH/gL heterodimer. The presence of this fusion machinery is absolutely required for fusion 
to proceed (Cai et al., 1988; Campadelli-Fiume and Menotti, 2007; Forrester et al., 1992; Roop 
et al., 1993). gL is necessary for incorporation of gH in the virion particle and its absence 
abrogates entry(Roop et al., 1993). It has been shown that gB binds to a variety of cellular 
receptors including the paired immunoglobulin-like type-2 receptor alpha (PILR-α), myelin-
associated glycoprotein (MAG) and non-muscle myosin heavy chain IIA (NMHC-IIA), however, 
the importance of this binding in the fusion process is yet to be determined(Arii et al., 2010; 
Chowdhury et al., 2012; Satoh et al., 2008; Suenaga et al., 2010). 
The fusogenic activity of gB is regulated by accessory proteins. Work in this laboratory 
has shown that gK and UL20 directly interact with gB and modulate its function in virus induced 
cell fusion. gM may indirectly participate in optimal gB fusigenic activity through interaction 
with pUL20 (Chouljenko et al., 2010; Foster et al., 2004; Kim et al., 2013; Melancon et al., 2005). 
Transport of capsids to the nucleus 
Upon fusion, the viral envelope is shed at the cell membrane and the nucleocapsids and 
tegument proteins are deposited in the cytosol. The outer tegument proteins such as pUL41, 
pUL47 and pUL48 (VP16) then dissociate from the nucleocapsid and the associated inner 
tegument proteins (Liu et al., 2010; Mettenleiter, 2006). pUL41, also known as the Virion Host 
Shutoff protein (VHS) inhibits the production of host proteins by inhibiting host mRNA synthesis 
and processing, and by speeding mRNA degradation. VHS targets both host and viral mRNAs, 
however, at late stages of infection viral mRNAs are rescued by VP16; which interacts with 
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pUL41 to inhibit its activity and to facilitate its incorporation into virion particles(Everly et al., 
2002; Lam et al., 1996; Roizman et al., 2007; Taddeo and Roizman, 2006). VP16 (pUL48), also 
known as alpha trans-inducing factor (αTIF) travels to the nucleus, forms a complex with the 
cellular protein Oct-1 and initiates the transcription of viral immediate early genes (Newcomb 
and Brown, 2009). Nucleocapsids and the associated inner tegument proteins are propelled 
along microtubules to the nucleus (retrograde transport) via the cellular motor molecules 
complex called Dynine. Anterograde transport from the nucleus to the plasma membrane is 
mediated by the Kinesin motor molecule (Diefenbach et al., 2008; Garner, 2003; Sodeik et al., 
1997). Inner tegument proteins pUL36, pUL37 and US3 remain in the capsid and their presence 
is required to recruit cellular transport motor molecules (Sodeik et al., 1997). After transport, 
capsids dock onto the nuclear pore complex and the viral DNA is extruded from the capsid into 
the nucleus (Figure 2-13). pUL36 plays an important role in DNA deposition into the nucleus 
through its interaction with the nuclear pore complex proteins(Batterson et al., 1983; Batterson 
and Roizman, 1983; Ojala et al., 2000; Sodeik et al., 1997). pUL36 acts as a plug to keep viral 
DNA packaged in the capsid. Cleavage of pUL36 is necessary to release viral DNA into the cell 
nucleus (Jovasevic et al., 2008). pUL25 is also involved in the release of viral genome into the 
nucleous; pUL25 interacts with nucleoporins CAN/Nup214 and hCG1. pUL25 also binds to the 
portal protein pUL6 and pUL36 (Jovasevic et al., 2008). 
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Figure 2.13: A colored electron micrograph of HSV-1 capsid at the nuclear pore complex (NPC).  
The figure shows an empty capsid shortly after deposition of viral DNA through the NPC. 
Adapted from (Bauer et al., 2013). 
 
Viral gene expression and DNA replication 
After deposition of viral genome in the nucleus, viral DNA circularizes forming endless 
genomes. It has been shown that cellular DNA ligase IV and the DNA repair protein XRCC4 are 
required for the formation of circular viral genomes during productive infection (Muylaert and 
Elias, 2007; Strang and Stow, 2005). Production of viral proteins can be classified based on the 
temporal gene expression into; immediate early genes or alpha gene expression, early genes or 
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Beta gene expression, and late genes or Gamma gene expression (Roizman et al., 2007). As 
discussed before, VP16 (alpha-TIF) dissociates from the tegument once in the cytoplasm, binds 
to host C1 and the complex then enters the nucleus and binds to Oct-1(Katan et al., 1990; 
Kristie and Sharp, 1990). This tripartite complex initiates the transcription of viral immediate 
early genes (alpha genes) (Newcomb and Brown, 2009). Alpha genes; ICP0, ICP4, ICP22, ICP27, 
ICP47 and pUS1.5 are expressed immediately after infection and their products peak at 2-4 
hours post infection. In general, alpha gene products are required for the activation of the 
expression of beta genes. ICP0 stimulates expression of all classes of viral genes (Everett, 2000). 
ICP4 is required for transcription of early and late gene promoters(Everett, 2000). Expression of 
beta genes peaks at 4-8 hours after infection. Beta gene products function in viral DNA 
replication process and gamma gene expression. Examples of beta gene products include; 
ribonucleotide reductase, thymidine kinase, viral DNA polymerase (UL30), DNA binding proteins 
(UL42 and UL29 or ICP8), ORI binding protein (UL9), and the helicase/primase complex (UL5, 8, 
and 52)(Muylaert et al., 2011; Roizman and Campadelli-Fiume, 2007). Gamma genes include 
structural viral proteins, tegument and glycoproteins and their gene expression peaks after viral 
DNA replication process has started. Gamma genes are divided into gamma 1 and gamma 2 
genes based on their temporal expression. Gamma 1 gene expression starts earlier sometimes 
as early as alpha genes (known as leaky genes), and gamma 2 genes are expressed only after 
DNA replication has begun. An example of gamma 2 genes include gK (Roizman and Campadelli-
Fiume, 2007). During viral replication, the origin-binding protein pUL9 facilitates loading of the 
viral replisome complex on viral genome origins of replication. Viral replisome complex is 
composed of the viral DNA polymerase (pUL30 and pUL42), a helicase-primase (pUL5, pUL8 and 
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pUL52), and the single-stranded DNA-binding protein pUL29 (ICP8)(Muylaert et al., 2011). Viral 
DNA replication uses a rolling circle mechanism and the newly formed viral genomes are 
produced. Host RNA polymerase II handles viral RNA transcription using the newly synthesized 
viral DNA as a template (Costanzo et al., 1977; Muylaert et al., 2011). In neurons, the virus 
establishes a latent infection where the productive lytic sequence of gene expression does not 
occur. Instead, viral genome remains in the nucleus in an episomal form and the non coding 
RNA latency associated transcript (LAT) accumolates in the nuclei of nurones. LAT silences other 
viral genes and protects nurones form apoptosis (Perng et al., 2000).   
Capsid assembly and DNA packaging 
Viral proteins are synthesized in the cytoplasm of infected cells. The structural 
components of the capsid are then imported to the nucleus for assembly. The overlapping UL26 
and UL26.5 gene products are cleaved to produce the scaffolding proteins VP21 and VP22a. 
UL26.5 also produces VP24 which is a protease that cleaves viral capsid scaffold proteins. Two 
copies of VP19C and one copy of VP23 form a complex in the cytoplasm and transport together 
into the nucleus.  Within the viral nuclear inclusion bodies, the major capsid protein VP5 binds 
to the scaffolding proteins VP21 and VP22a forming 125 nm spherical pro-capsids as hexones, 
pentons and triplexes are assembled(Brown and Newcomb, 2011; Nicholson et al., 1994; Rixon 
et al., 1996; Roizman et al., 2007). DNA packaging into the capsid occurs through the portal 
(composed of 12 copies of pUL6). The viral terminase complex composed of pUL15, pUL28 and 
pUL33 aids in viral DNA packaging by cleaving the viral DNA concatomers into monomers. 
Maturation of capsid takes place as VP24 (protease) cleaves the scaffolds and the capsid starts 
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to assume mature polyhedral shape(Brown and Newcomb, 2011). As the capsid angularizes, 
VP26 assembles on the maturing capsid in an energy dependent manner(Chi and Wilson, 2000). 
After that, pUL36 is recruited at the portal to serve as plug keeping the viral DNA securely 
contained within the capsid(Jovasevic et al., 2008). 
Primary envelopment  
The relatively small nuclear pore (~39 nm) does not allow the passage of the 125 nm 
diameter of the viral capsid to the cytoplasm. The relatively large capsids bud into the inner 
nuclear membrane forming enveloped capsids in the peri-nuclear space, then the enveloped 
capsids undergo de-envelopment at the outer nuclear membrane to exit into the cytoplasm. 
This model is known as the envelopment and de-envelopment pathway (Hofemeister and 
O'Hare, 2008; Johnson and Baines, 2011).  
Acquisition of an envelope at the inner nuclear membrane is mediate by pUL31 and 
pUL34. pUL34 is a virus-encoded membrane anchored protein present at the inner nuclear 
lamina and forms a heterodimer with pUL31(Shiba et al., 2000). The pUL34/pUL31 complex, 
also known as the nuclear egress complex (NEC), recruits viral and cellular kinases to 
phosphorylate and soften the nuclear lamina (Mettenleiter et al., 2013; Reynolds et al., 2001; 
Roller et al., 2000). The NEC recruits cellular kinases such as protein kinase C alpha and C delta 
to phosphorylate lamin B, whereas, lamin A and lamin C are phosphorylated by the viral kinases 
pUS3 and pUL13. Phosphorylation of lamins disrupts and dissolves the nuclear lamina allowing 
the interaction of nucleocapsids with the inner nuclear membrane (Mettenleiter et al., 2013; 
Mou et al., 2007; Park and Baines, 2006). C-capsids (DNA-containing capsids) are preferentially 
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selected for the primary envelopment process. UL31 protein favorably binds to pUL25 
component of the C-capsid specific (CCSCs) at capsid vertices. It can also interact with the 
pUL17 CCSC component in the absence of pUL25 (Yang et al., 2014). Both pUL31 and pUL34 
have been detected in virions present in the perinuclear space. Interestingly however, mature 
virions do not contain pUL31 and pUL34 (Fuchs et al., 2002b).  
Nucleocapsids with a primary envelope are already coated with a thin layer of tegument 
proteins, and the rest of tegument proteins will be added before or during secondary 
envelopment (Mettenleiter, 2002; Mettenleiter et al., 2009; Padula et al., 2009). In a process 
called de-envelopment, the enveloped nucleocapsids in the perinuclear space fuse with the 
outer nuclear membrane to exit to the cytoplasm. The core fusion machinery gB and gH/gL 
which is involved in virion fusion during entry also mediates the de-envelopment process. 
Deletion of gB and gH leads to accumulation of enveloped virions in the peri-nuclear space 
(Farnsworth et al., 2007b; Wright et al., 2009). Furthermore, phosphorylation of gB by the viral 
kinase pUS3 promotes the fusion of enveloped nucleocapsids with the outer nuclear membrane 
(Wisner et al., 2009).  
Secondary envelopment 
Nucleocapsids released into the cytoplasm acquire more tegument as they travel to the 
site of secondary envelopment at trans-Golgi network (TGN) derived vesicles and endosomes. 
Already covered with a thin layer of tegument, capsids get coated with more pUL36 and pUL37 
tegument proteins. Nucleocapsids are propelled along microtubules to the sites of secondary 
envelopment at the TGN as a result of the interaction between pUL36 and pUL37 tegument 
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proteins and the cellular motor molecule Kinesin.  Also, the presence of pUL36 and pUL37 is 
required for the successful incorporation of other tegument proteins (Luxton et al., 2006; 
Sandbaumhuter et al., 2013).  
Additional tegument proteins are added to the capsid during the secondary 
envelopment; tegument proteins bind to the cytoplasmic surface of TGN membranes and as 
the capsids bud into TGN derived vesicles they acquire envelops (Johnson and Baines, 2011).  
After expressed in the cytoplasm, viral envelope proteins are sorted to the TGN 
membranes where the carboxyl termini facing towards the cytoplasm. Viral glycoproteins are 
subjected to modifications by mannose-6-phosphate (M6P), and they contain a variety of 
sorting domains, including di-leucine motifs, tyrosine motifs and acidic clusters, similar to those 
found on host TGN proteins. The above mentions modifications and the presence of sorting 
domains facilitate sorting of viral glycoproteins such as gB, gD, gE/gI to TGN (Beitia Ortiz de 
Zarate et al., 2004; Gu et al., 2001; McMillan and Johnson, 2001).  
A complex network of interactions between the capsid and tegument proteins, and the 
carboxyl termini of envelope glycoproteins facilitate secondary envelopment (Figure 2.14).   
The inner tegument protein pUL36 have been shown to interact with capsid proteins 
VP5 and pUL25 and acts as the link between the capsid and the outer tegument proteins (Bucks 
et al., 2011; Coller et al., 2007). Also, pUL36 and pUL37 interact with pUL48 andpUL46, 
respectively. pUL48, an outer tegument protein, interacts with the tegument proteins pUL41, 
pUL46, pUL47 and pUL49 (Elliott et al., 1995; Newcomb and Brown, 2009; Smibert et al., 1994; 
Vittone et al., 2005). pUL21 and pUL16 form a complex; this interaction has been documented 
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in HSV-1 and PRV (Klupp et al., 2005). pUL16 also interacts with the membrane-associated 
tegument protein UL11(Loomis et al., 2003; Yeh et al., 2008). pUL11 in turn, interacts with gD 
and gE serving as a bridge between the tegument covered capsid and the envelope to facilitate 
secondary envelopment(Farnsworth et al., 2007a; Meckes et al., 2010; Yeh et al., 2008). The 
cytoplasmic domains of gE and gD and gM interact with pUL49 (VP22) which presence is 
important for the incorporation of gD, gE/gI and ICP0 into virions (Stylianou et al., 2009) (Chi et 
al., 2005; Farnsworth et al., 2007a; O'Regan et al., 2007). Interestingly, absence of pUL49 (VP22) 
does not affect the incorporation of ICP4, the binding partner of ICP0, in virion particles (Duffy 
et al., 2006; Elliott et al., 2005; Yao and Schaffer, 1994).  Recruitment of VP22 into virion 
particles is also dependent on its interaction with the cytoplasmic tail of gE(Stylianou et al., 
2009). The interaction between pUL48 and the cytoplasmic portions of gB, gD and gH has been 
documented using chemical cross-linking assays and protein pull-down experiments (Foster and 
Kousoulas, 1999; Kamen et al., 2005; Zhu and Courtney, 1994). In addition to phosphorylation 
of nuclear lamina, pUL13 phosphorylates both gE and pUL49 and modulates pUL41 function 
(Coulter et al., 1993; Ng et al., 1998; Overton et al., 1994). 
Another complex network of interactions between viral membrane and the inner 
tegument has been reported. Proximity ligation assay and co-immunoprecipitation experiments 
showed that the inner tegument protein UL37 binds to the membrane proteins pUL20 and gK 
highlighting (Jambunathan et al., 2014). Also, the cytoplasmic portion of gD has been shown to 
bind directly to the capsid (Chi et al., 2005).  
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Figure 2.14: Schematic illustration of viral protein interactions during secondary envelopment. 
Yellow rectangles denote tegument proteins. Adapted with permission from PhD dissertation 
titled “The Role of Viral Glycoproteins and Tegument Proteins in Herpes Simplex Virus Type 1 
Cytoplasmic Virion Envelopment” by Dmitry V. Chouljenko, Louisiana State University, School of 
Veterinary Medicine, Department of Pathobiological Sciences, August 2014. 
 
gK and the non-glycosylated membrane protein UL20 play important roles in 
cytoplasmic envelopment and egress(Foster and Kousoulas, 1999; Jambunathan et al., 2014). 
And as discussed above, the gD (carboxyl terminus), gE, gM, and the membrane-associated 
protein UL11 play important roles in cytoplasmic virion envelopment and egress from infected 
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cells. The relative importance of gD, gE, gM, gK, pUL20 and pUL11 in virion secondary 
envelopment and egress have been studied. Lack of gK and UL20 causes the most severe 
perturbances in virion envelopment and egress (Chouljenko et al., 2012; Foster and Kousoulas, 
1999; Jambunathan et al., 2014). 
Nucleocapsids obtain envelops as they bud into vesicles derived from TGN. These 
vesicles are enriched with viral envelope glycoproteins. This budding process is topologically 
similar to the formation of intraluminal vesicles in multivesicular bodies in cells. Formation of 
intraluminal vesicles in multivesicular bodies is mediated by the endosomal sorting complexes 
required for transport (ESCRTs) and the ATPase VPS4 complexes. Experiments using 
ESCRTdominant-negative cells, as well as RNA interference experiments revealed that ESCRT 
proteins are likely involved in virion envelopment in both HSV-1 and HCMV. It has been shown 
that gK possesses a putative ESCRT-binding motif which possibly participates in the recruitment 
of ESCRT protein to facilitate membrane curvature during the budding process. Interestingly, 
ESCRT-III proteins and VPS4A/B have been shown to be incorporated into mature HSV-1 virions 
(Pawliczek and Crump, 2009). 
Egress of enveloped virions 
After secondary envelopment, enveloped virions enclosed within TGN derived vesicles 
are transported to the plasma membrane and released to the extracellular space via exocytic 
pathways(Johnson and Baines, 2011; Mettenleiter, 2002; Mettenleiter et al., 2009). The 
transport process is assisted by myosin Va and the cellular serine-threonine protein kinase D. 
Myosin Va translocate enveloped virion laden cellular vesicles along cortical actin filaments 
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(Roberts and Baines, 2010). The cellular serine-threonine protein kinase D is involved in scission 
of TGN vesicles. It also regulates their transport to the basolateral cell membrane (Remillard-
Labrosse et al., 2009). In polarized epithelial cells, TGN-derived vesicles containing enveloped 
virions are sorted to cell-cell junctions where they fuse with the plasma membrane and release 
virions (Mettenleiter, 2002). Sorting of virus containing TGN vesicles to cell junctions is 
presumably mediated by gE/gI membrane protein complex and the inner tegument protein 
pUL37 (Johnson et al., 2001; Pitts et al., 2014). Placing virions at the cell to cell junction 
facilitates cell to cell spread and protects the virus from exposure to host immune response 
elements such as antibodies and complement (Johnson and Baines, 2011). Syncytial cells are 
large multinucleated cells formed by the fusion of cell membranes of multiple cells after 
infection in vivo.  Plasma membranes of infected cells are enriched with viral glycoproteins. 
Viral entry fusion machinery expressed on infected cell membranes mediate the fusion of 
adjacent cells creating syncytia.  Syncytia formation is particularly beneficial to the virus as it 
helps the virus hide from immune surveillance (Roizman et al., 2007). The fusion of TGN-
derived vesicles containing enveloped virions is unlikely mediated by viral glycoprotein 
embedded in the vesicles membranes. Viral glycoproteins embedded in TGN-derived vesicles 
are oriented so that the carboxyl termini are to the cytoplasm. The amino termini of these 
glycoproteins are located within the vesicles and do not come in contact with the cell plasma 
membrane to mediate fusion (Johnson and Baines, 2011).  
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Retrograde and Anterograde Transport of Alphaherpesviruses in Neurons 
Neuronal structure and axoplasmic transport 
Neurons are highly polarized cells with unique structure; they are composed of cell 
bodies which contain the nucleus, and highly active RNA transcription machinery known as Nissl 
substance. Neurons have dendritic extensions and an axon that specializes in initiation; 
propagation and transmission of electrical impulses. The axon has an efficient transport system 
for long distance cargo transport to move molecules and organelles between the body of the 
body of the neuron and axonal termini. Microtubules are key structural elements in the axon. 
Microtubules are composed of heterodimeric subunits of alpha and beta tubulins that assemble 
in a linear head to tail configuration to form protofilaments. Then, 13 protofilaments form a 
hollow conduit, approximately 24 nm in diameter. Microtubules assemble from Microtubule 
Organizing Center (MTOC) with distinct polarity; in the axon they are oriented so that an active 
+ end is towards the axonal termini, whereas, a stable – end is oriented towards the MTOC. In 
dendrites, microtubules have mixed polarity. The end microtubule at the proximal axon 
contains filamentous actin, microtubule end binding (EB) proteins EB1 and EB3. Ankyrin G acts 
as a scaffold to anchor these structural components together. The proximal axon and its 
complex elements regulate the transport of cellular components to the axonal compartment 
(Kramer and Enquist, 2013), (Hedstrom et al., 2008; Leterrier et al., 2011; Song et al., 2009). 
Transport within axons is mediated by two classes of motor molecules kinesin and 
dynein. Both use ATP hydrolysis to drive the transport. Dynein is a 1.2 megadalton that contains 
heavy chains, intermediate chains, light intermediate chains and light chains. Dynein forms a 
59 
 
dynactin complex with multiple subunits to bind various molecules. Dynein motor molecule 
mediates microtubule-dependent retrograde transport (towards the – end). Kinesin superfamily 
(KIF) is markedly more diverse. KIFs are classified into 3 broad categories; N-kinesins M-
kinesins, C-kinesins depending on the position of the motor domain; near the amino terminus, 
near the middle, or near the carboxyl terminus, respectively. KIFs mediate microtubule 
dependent transport towards the + end (anterograde transport) (Diefenbach et al., 2008; 
Goldstein and Yang, 2000; Hirokawa et al., 2009; King, 2000; Schroer, 2004).   
Virus binding, attachment and entry  
Mature infectious virion particles initiate the infection of neurons virion attachment to 
the cellular receptors. The envelope glycoprotein gC and gB attach to glycosaminoglycane 
chains of heparan sulfate proteoglycanes, this initial attachment does not require energy 
(Kramer and Enquist, 2013; Laquerre et al., 1998; WuDunn and Spear, 1989). After that, gD 
binds to a wide variety of receptors on cell membrane. Cellular receptors for gD include 
members of tumor necrosis factor receptor family (TNF) such as herpes virus entry mediator A 
(HVEM or HveA). Members of immunoglobulin superfamily also serve as receptors for gD; 
examples include nectin-1, nectin-2, paired immunoglobulin-like type 2 receptor alpha (PILR-2 
alpha) and 3-O sulfated heparan sulfates. Nectin-1 is present on the sensory neuronal endings. 
VZV encodes gE that may have gD like functions during binding, a proposed receptor for VZV gE  
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is the insulin degrading enzyme.  Binding of gD to its cognate receptor triggers conformational 
changes in gB, gH, and gL which leads to the fusion of viral envelope with cell membrane. 
(Heldwein and Krummenacher, 2008; Kramer and Enquist, 2013; Li et al., 2007; Roizman et al., 
2007).  
During binding and fusion, viral tegument proteins are reorganized to become 
asymmetrically distributed so that the dense aggregation faces away from the cell (Meckes and 
Wills, 2008; Smith, 2012). HSV-1 enters neuronal cells via a pH-independent fusion of the viral 
envelope with neuronal plasma membranes (Nicola et al., 2005; Qie et al., 1999), while it can 
enter a wide range of non-neuronal cells via either pH independent or pH-dependent 
endocytosis (Milne et al., 2005).  
Viral tegument proteins are classified into inner and outer tegument proteins. Inner 
tegument proteins are: pUL14, pUL16, pUL21, pUL36, pUL37, pUS3, and ICP0 (Kramer and 
Enquist, 2013; Radtke et al., 2010). Outer tegument proteins are; pUL46, pUL47, VP16, and 
VP22 (Luxton et al., 2005; Smith, 2012).   Tegument proteins dissociate from the capsid upon 
entry into the cytosol. However, a subset of inner tegument proteins (UL36, UL37 and US3) 
remain attached to the capsid. These three inner tegument proteins participate in the 
retrograde axonal transport of capsid to the nucleus (Copeland et al., 2009; Kramer and 
Enquist, 2013; Luxton et al., 2005; Smith, 2012).  
Retrograde transport  
After virus-cell membrane fusion and deposition of capsid and the attached inner 
tegument proteins in the cytosol, the capsid is transported in retrograde manner to the 
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nucleus. It has been shown recently that alphaherpesviruses induce local protein synthesis in 
axons for efficient retrograde transport. Proteins involved in cytoskeletal reorganization, cell 
singling and metabolism are among the infection induced proteins (Koyuncu et al., 2013). 
Retrograde transport depends on intact microtubules and the motor complex; Dynein 
and the dynein co-factor dynactin. Alphaherpesvirus capsids transport to the nucleus at a rate 
of 1 µm/s which is consistent with the fast retrograde axonal transport. As expected capsid 
transport was abolished when cells were pretreated with microtubule depolymerizing agent 
such as Nocodazol and colchisin. This indicates that the virus exploits and piggy back on 
preexisting axonal transport mechanisms. Multiple capsid and tegument proteins have been 
proposed to be involved in the recruitment of dynein motor molecule for retrograde transport.  
pUL34 and pUL9 have been shown to bind to dynein 1 intermediate chain (DYNC11)1a,  and LC8 
respectively, in vitro (Diefenbach et al., 2008; Kramer and Enquist, 2013; Ye et al., 2000). 
However, neither is incorporated in mature virion particles. Moreover, deletion of pUL34 did 
not prevent infection with HSV-1 (Reynolds et al., 2002; Roller et al., 2000). UL35 encodes VP26; 
a structural capsid protein. Studies have demonstrated that VP26 interacts with the dynein light 
chain (Tctex-1), both in yeast two-hybrid system and in vitro (Diefenbach et al., 2008; Douglas 
et al., 2004). Inner tegument proteins UL36, UL37 and US3 have emerged as candidates for 
virus-motor molecule interaction. Deletion of UL37 and US3 did not cause dramatic disruption 
in viral retrograde transport. However, UL36 null mutants were largely unable to reach the 
nucleus (Kramer and Enquist, 2013; Luxton et al., 2006). US9 null viruses do not exhibit defects 
in the retrograde transport (Brideau et al., 2000a).  
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Deposition of Viral DNA into the nucleus 
After capsids reach the minus end at the MTOC, they translocate to the nuclear pore 
complex where viral DNA is released into the nuclear pore. Proteolytic cleavage of UL36 after 
docking to the NPC induces conformational changes that lead to the release of viral DNA into 
the nucleus (Jovasevic et al., 2008). pUL25 capsid protein have been shown to interact with 
nuclear pore complex components (Nup 214 and hCG1). It is possible that this pUL25 plays a 
role in DNA release into the nucleus (Smith, 2012). Once inside the nucleus the linear viral DNA 
circularizes and serves as a template for replication (Roizman et al., 2007).  
Nuclear egress 
A heterodimeric complex composed of pUL34 and pUL 31 (NEC) mediates the primary 
envelope-mediated nuclear egress of the nucleocapsid into the perinuclear space. This complex 
recruits viral kinases (US3 and pUL13) and cellular protein kinase C to locally phosphorylate and 
soften the nuclear lamina. (Leach and Roller, 2010; Mettenleiter et al., 2013). The initial 
budding through the inner nuclear membrane is followed by fusion and de-envelopment event 
at the outer nuclear membrane. pUS3 is involved in the de-envelopment and translocation of 
nucleocapsid from the periuclear through the outer nuclear membrane (Mettenleiter et al., 
2013; Mou et al., 2009). 
Married model vs separate model in anterograde transport 
The mechanism of anterograde transport of alpha herpesvirus in neuronal cells is highly 
controversial, to a large extent because of disparate results obtained with pseudorabies virus 
63 
 
(PRV) and HSV-1. Two principal mechanisms of axonal transport have been proposed: (i) 
independent axonal transport of viral glycoproteins and capsids and assembly of the enveloped 
virions in the plasma membrane (separate model) and (ii) transport of fully enveloped virions 
that have formed via budding of capsids into TGN-derived membranes (married model) 
reviewed in (Diefenbach et al., 2008; Kratchmarov et al., 2012). 
Evidence for the married model. Live cell imaging of double labeled viruses in proximal 
and distal regions of axons after infection of primary neuronal cultures of dorsal root ganglia 
(DRG) of embryonic rats revealed that there is a co-localization of capsid and membrane 
protein signals during anterograde experiments. Antinone et al 2006 have constructed 
recombinant PRV viruses with GFP labeled gD and mRFP labeled Vp26 (Antinone and Smith, 
2006). The two fluorescent signals co-localized in 86% of particles traveling in anterograde 
direction. However, 14 % of mRFP signal had no GFP signal associated with it. This lack of co-
localization can be attributed to limitations in detectability. Taylor et al 2012 had similar dual 
signal using GFP-US9 labeled PRV virus (Antinone and Smith, 2006; Taylor et al., 2012). Imaging 
of dual-fluorescent HSV-1 recombinant viruses were shown to support the married model. HSV 
virus expressing mRFP-VP26 and GFP-gB was reported to have 70% co-localization of both 
signals in chicken and rat DRG(Antinone et al., 2010). Recent high resolution electron 
microscopic imaging of neurons infected with PRV or HSV-1 showed that the majority 
(approximately 70%) of virions travel in anterograde manner are enveloped (Negatsch et al., 
2010).  
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Evidence for the separate model. Immunofluorescent antibody (IFA) technique was 
used to determine the assembly state of virion particles in anterograde set up experiments. 
Fluorescent antibodies against capsid proteins and envelope proteins have shown minimal co-
localization supporting the separate model (Snyder et al., 2006). Cell imaging using cryo-
electron tomography on hippocampal axons revealed that axons predominantly contained 
naked capsids (Ibiricu et al., 2011).  
It is clear that the support for the separate model tends to depend on negative 
evidence. Limitations of detection in IFA techniques would significantly confound the final 
interpretation. Also, hippocampal neurons tend to develop long and arborized dendrites, and 
the cryo-electron microscopy pictures were obtained without identification of the exact 
sections of axons. Transport in dendrites has not been characterized before. Therefore, the 
assembly status of the virion traveling in dendrites in anterograde manner may not be the same 
as in axons (Kratchmarov et al., 2012). 
Anterograde transport  
Once in the cytosol, nucleocapsids obtain inner tegument proteins including UL36, UL37 
and US3. UL 36 is essential for secondary envelopment and egress events. UL36 also interacts 
with motor proteins to transport the capsid to the site of secondary envelopment.  The 
nucleocapsids and associated tegument composition of incoming virions is similar to the newly 
formed. Which pauses the question; how are capsids differentially directed to the nucleus upon 
entry or to the site of secondary envelopment during egress?. Post translational modifications 
or other subtle but important differences in tegument component may govern the differential 
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targeting of capsids to the nucleus during entry, and newly formed capsids to the site of 
secondary envelopment (Kramer and Enquist, 2013; Smith, 2012).  
UL36 and US11 are viral protein candidates for recruitment of kinesin motor molecules 
during anterograde transport. Both proteins have been shown to interact with kinesin in 
biochemical assays. However, UL36 and US11 are components of virion tegument and they are 
unlikely to participate in the anterograde transport of enveloped virions. (Kramer and Enquist, 
2013).  
US9, gE and gI play important roles in sorting enveloped virions into the axonal 
compartment. HSV-1 gE is a type 1 membrane glycoprotein of 552 amino acids. gE is expressed 
as a heterodimer with gI; the complex facilitates cell to cell spread by sorting newly formed 
virion particles to cell junctions and lateral cell surfaces (Collins and Johnson, 2003).  
The cytoplasmic tail of PRV gE (last 123 amino acids) contains tyrosine based 
internalization motif (specifically amino acids 478-481). This motif is important in gE/gI 
constitutive endocytosis from the plasma membrane. gE-null or gE cytoplasmic tail deleted 
viruses have a small plaque phenotype in non-neuronal- cell type, and defective for 
anterograde spread in neurons in vivo (Brideau et al., 2000b; McGraw et al., 2009). gE/gI 
complex also stabilizes the interaction of US9 with KIF1A (kinesin motor protein important in 
anterograde transport) (Kratchmarov et al., 2013a). 
US9 is a type II membrane anchored protein. US9-null viruses produce similar plaque-
size as wild type in epithelial cell tissue culture. However, mutants lacking US9 are defective in 
anterograde transmission (Chowdhury et al., 2011; Lyman et al., 2007; Taylor et al., 2012). US9 
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was also found to interact with KIF1A(Kramer et al., 2012). US9 has an acidic cluster of 10 
amino acids, within the cluster Y49 and Y50 are known to be required for US9-KIF1A interaction 
and to be important for productive anterograde spread in vivo (Brideau et al., 2000b; Kramer et 
al., 2012; Kratchmarov et al., 2013b). Moreover, phosphorylation of two serine residues S51& 
S53  in the acidic cluster of US9 was shown to be essential for anterograde spread in vivo 
(Brideau et al., 2000b; Kratchmarov et al., 2013b). Although not essential, phosphorylation of 
the two serine residues S51 & S53 enhances the US9-KIF1A based transport (Kratchmarov et al., 
2013b). The S51 & S53 serine residues in US9 are conserved in BHV-1, HSV-1, HSV-2, VZV, EHV-
1, BHV-1, BHV-5 (Chowdhury et al., 2011) and PRV. 
Herpes Simplex Virus Diseases 
Herpes simplex virus infection causes a wide range of clinical manifestations ranging 
from vesicles on the mucocutaneous membranes to fatal encephalitis (Roizman et al., 2007). 
Being an enveloped virus, HSV-1 is susceptible to desiccation, UV radiation, and lipid solvents. 
Therefore, transmission of the virus is by the direct and intimate contact with individuals 
shedding the virus. After infection the virus is shed from the site of infection for 7-10 days (Amir 
et al., 1997). Serum neutralizing antibodies can be detected as early as 4-7 days post infection 
and peak at 3 weeks post infection (Buddingh et al., 1953). The seroprevalence for Herpes 
simplex virus in USA and Europe is estimated to be 70-85% (Fatahzadeh and Schwartz, 2007; 
Looker and Garnett, 2005; Nahmias et al., 1990).  Seroprevalence to HSV-1 is more common 
than to HSV-2(Nahmias et al., 1990). HSV-1 usually is an oral infection whereas HSV-2 infects 
genitalia. Increasing reports have showed that both viruses have been detected at alternate 
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sites; however, HSV-1 infections of the genitalia tend to be less severe with lower frequency of 
recurrence (Corey et al., 1983; Kalinyak et al., 1977). Approximately 30% of genital herpes 
infections in the U.S. are caused by HSV-1. However, in specific populations such as college 
students in the US, HSV-1 accounts for up to 78% of genital isolates (Kimberlin, 2014; Roberts et 
al., 2003). A global prevalence study showed that the total number of people aged 15-49 years 
who are infected with HSV-2 in 2003 is 536 million (Looker et al., 2008).  
Herpes labialis 
Herpes labialis or cold sore is infection of the mucocutaneous areas of the lips and 
mouth. It is the most common manifestation of herpes simplex infection (Roizman et al., 2007; 
Whitley and Miller, 2001). The virus infects and replicates in epithelial cells of the oropharynx. 
This primary infection may result in vesicular lesions or bullae at the site of inoculation, but the 
primary infection can also be asymptomatic. Histologically; the bulla will appear as an 
intraepidermal vesicle containing serofibrinous fluid and swollen, acantholytic keratinocytes, 
some of which has eosinophilic intranuclear inclusion bodies (Figure 2.15).  
 Vesicles may rupture leading to erosion and ulceration, and occasionally the herpes 
infection is complicated by secondary bacterial infection. The virus eventually infects sensory 
nerve endings and transports to the body of the neuron in the trigeminal ganglia where it 
establishes persistent (latent) infection for the life of the host. Triggered by a number of stimuli 
such as stress and UV light, latent virus may reactivate resulting in the transport of the virus to 
the initial site of infection where it replicates and causes outbreaks of recurrent vesicular 
lesions (Baron et al., 1996; Roizman et al., 2007).  
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Figure 2.15: Hematoxylin and eosin stained histological section of herpes labialis showing an 
intraepidermal vesicle containing serofibrinous fluid and swollen, acantholytic keratinocytes, 
some of which has eosinophilic intranuclear inclusion bodies. The dermis is infiltrated with 
inflammatory cells. Adapted from Weedon: Skin Pathology 3rd edition (2010). 
 
The frequency and the severity of the recurrent infection varies between individuals, 
approximately 30% of seropositive individuals experience recurrences with 40% of them have a 
recurrence once a year (Wald and Corey, 2007). Recurrent disease is often presented with 
tingling or itching, and pain for nearly 6 hours. These symptoms are then followed by the typical 
cold sore vesicle formation within 24-48 hours (Spruance, 1984; Spruance et al., 1977) 
(Spruance and Crumpacker, 1982). The vesicular lesion usually resolves on average after seven 
days (Segal et al., 1974; Ship et al., 1977). Recurrent infection and viral shedding can also be  
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asymptomatic (Fatahzadeh and Schwartz, 2007; Koelle and Wald, 2000). Intraoral and 
pharyngeal lesions accompanied by fever are known as Gingivostomatitis are more common in 
children younger than five years old (Roizman et al., 2007).  
Herpes simplex ocular disease 
Herpes simplex ocular disease is one of the serious consequences of HSV infection. 
Ocular herpes virus infection is the leading cause of infectious blindness in the developed 
world. Approximately 400,000 people in the United States have suffered herpes simplex ocular 
disease with 58,000 total episodes per year. A recent study has estimated the average annual 
incidence of new cases to be 11.8 per 100,000 population. The prevalence is approximately 149 
cases per 100,000 population (Liesegang, 2001; Liesegang et al., 1989; Young et al., 2010).  
Primary ocular infection can cause ocular disease, but frequent episodes of reactivation 
lead to more devastating consequences. Herpes simplex virus infected eyes manifest as 
conjunctivitis, blepharitis, ocular discharge and keratitis (Darougar et al., 1985; Rowe et al., 
2013; Zhu and Zhu, 2014).  The majority of herpes ocular infections are caused by HSV-1 rather 
than HSV-2 (Roizman et al., 2007). Herpes virus infection of the cornea can be divided into; 
epithelial keratitis which accounts for 50%-80% of all ocular herpes infection, and stromal 
keratitis (Labetoulle et al., 2005; Wilhelmus et al., 1981).  
In epithelial keratitis, the virus replicates in corneal epithelial cells and causes epithelial 
cell destruction.  It manifests initially as small vesicles that coalesce and ultimately rupture 
leading to what is known as dendritic ulcers. Dendritic ulcers in the cornea appear as central 
ulcerations with raised borders, and terminal end bulb (Figure 2.16). Inflammatory cell 
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infiltrates include polymorphonuclear cells, lymphocytes and plasma cell, occasional syncytial 
cell formation and eosinophilic intranuclear inclusions (Maudgal and Missotten, 1978; Metcalf 
and Reichert, 1979). 
 
Figure 2.16: Epithelial keratitis caused by HSV-1; Dendritic ulcer in the corneal epithelium 
shown here with fluorescein staining. The image was taken from 
http://medilinks.blogspot.com/2012/01/photos-for-herpes-simplex-keratitis-hsk.html 
 
Stromal keratitis is characterized by stromal edema, neovascularization, necrosis and 
inflammatory infiltrates. Repeated bouts of reactivation lead to corneal stromal scaring. Even 
after clearance of inflammatory cells, new blood vessel growth in the cornea and the 
destruction of the structural integrity of the stroma cause marked opacity and vision 
impairment (Figure 2.17)  (Zhu and Zhu, 2014) (Rowe et al., 2013) (Gimenez et al., 2013).  
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Figure 2.17: Slit lamp photograph of Herpes simplex stromal keratitis. Note stromal opacity and 
neovascularization of the cornea (Rowe et al., 2013). 
 
The infection can spread to deeper eye structures and cause infection and inflammation 
of the anterior chamber, iris and retina (David et al., 2008; Holland et al., 1987; Liesegang, 
2001).  However, the acute retinal necrosis, iridocyclitis and panuveitis are rare in 
immunocompetent individuals (Zhu and Zhu, 2014).  Severe stromal destruction and corneal 
opacity may be treated with corneal transplants, however, reactivation of latent virus from the 
trigeminal ganglia can cause graft failure(Cockerham, 2001; Cockerham et al., 1997; De Kesel et 
al., 2001; Tullo, 2003).  
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One of the possible consequences of herpes ocular infection is neurotrophic 
keratopathy; a loss of sensation in the cornea due to degeneration of sensory nerves (Hamrah 
et al., 2012; Liesegang, 1999). Loss of sensation in the cornea may also lead to reduction in tear 
film production (dry eye), which increases the chances for corneal abrasions and ulcerations, 
inflammation, secondary bacterial infection and increased frequency of herpetic ocular 
recurrences (Tullo, 2003) (Keijser et al., 2002). 
Role of corneal epithelial cells in the pathogenesis of primary herpes keratitis. The 
annual incidence of new cases of herpes keratitis is 11.8 per 100,000 population (Liesegang et 
al., 1989; Young et al., 2010). Infection starts by the entry and replication of the virus in 
epithelial cells at site of exposure, followed by entry into sensory neurons via their axonal 
termini. The virus recruits cellular transport machinery to translocate in retrograde manner to 
the body of the neuron. In the neuronal cell body, the virus remains latent for the life of the 
host. Exposure to UV light or immunosuppression leads to bouts of reactivation whereby the 
virus transports in anterograde manner to the primary site (Roizman et al., 2007). 
The innate immune system is the first line of defense against pathogens. Cells of the 
innate immune system are equipped with Pattern Recognition Receptors (PRRs) which serve as 
sensors for conserved pathogen associated molecular patterns (PAMPs) displayed on the 
invading pathogens(Boehme and Compton, 2004). Toll like Receptors (TLRs) are a class of PRRs 
that are expressed predominantly on cells that are likely to first encounter the pathogen. 
Professional antigen presenting cells and phagocytic cells express the highest levels of TLRs 
(Akira et al., 2006; Medzhitov, 2007). In general, binding of PAMPs to TLRs leads to the 
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production of pro-inflammatory cytokines, and interferons, and up regulation of co-stimulatory 
molecules(Yamamoto and Takeda, 2010).  
Corneal epithelial cells are one of the most important active participants in herpes 
Simplex keratitis.  They are the first cell type to encounter the virus upon primary ocular 
infection with HSV. Corneal epithelial cells not only take part in pathogen recognition via the  
expression of a wide range of PRR including  TLR-2, TLR-7 and TLR-9 (Johnson et al., 2005; 
Kumar et al., 2006; Li et al., 2006) but also secrete  β-defensins, cytokines and chemotactic 
factors upon microbial invasion(Akpek and Gottsch, 2003). 
TLR2 plays a key role in the recognition of a wide range of in microbial antigens from 
bacteria, fungi, parasites and viruses reviewed in (Kawai and Akira, 2010). TLR2 generally forms 
heterodimers with TLR1 or TLR6. Moreover, TLR2 has the ability to act together with other cell 
surface receptors to assist PAMP recognition. These include CD36 and CD14 (Hoebe et al., 2005; 
Jiang et al., 2005). Generally, binding of PAMPs to TLR-2 leads to the downstream signaling 
through MyD88 dependent pathway which activates NF-kB and promotes the production of 
pro-inflammatory cytokines such as IL-1, IL-6, IL-8, and IL-12 (Kawai and Akira, 2010). It has 
been demonstrated that TLR-2 recognizes structural components of viruses (Bieback et al., 
2002; Cooper et al., 2005). Members of herpes virus family bind to and activate TLR-2 MyD88 
dependent pathways (Ariza et al., 2009; Boehme et al., 2006; Wang et al., 2005). HSV-1 gB has 
been shown to interact with TLR-2 which leads to pro-inflammatory cytokine production via 
MyD88 dependent signaling. This binding and downstream cascade activation did not require  
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CD14 (Cai et al., 2013; Leoni et al., 2012; Sato et al., 2006). HSV-1 gB recognition occurs 
predominantly by TLR-2/TLR6 heterodimer and to a lesser extent by TLR-2/TLR heterodimer 
(Cai et al., 2013).  
Following a primary infection with HSV-1, the cornea is infiltrated with a diverse set of 
inflammatory cells composed of; neutrophils (the predominant cell type), macrophages, natural 
killer cells (NK), T cells, and corneal dendritic cells (Miller et al., 1996; Stuart and Keadle, 2012). 
The development of primary herpes keratitis is believed to be a result of interaction of virus 
with the innate immune system rather than a direct viral cytopathic effect on corneal 
cells(Stuart and Keadle, 2012).  
During primary keratitis, the infection induces the production of IL-6, which stimulates 
the production of neutrophils chemotactic factors (CCL3 and CXCL2). CCL3 and CXCL2 along 
with CCL1, CCL4, CCL5 CXCL10 attract monocytes, NK cells and DCs(Stuart and Keadle, 2012). 
Also, the levels of pro-inflammatory cytokines IL-1 alpha and IL-6 were increased upon primary 
herpes corneal infection. This increase was followed by an overlapping set of cytokine 
production (IFN-gamma, IL-12, IL-17, IL-4 and IL-10). This cytokine profile is indicative of the  
involvement of CD4+ T cells; Th1 and Th17 in the immune response (Biswas et al., 2004; 
Niemialtowski and Rouse, 1992; Stuart and Keadle, 2012). CD8+ cells play a minor role in the 
disease(Stuart and Keadle, 2012).  
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TLR-2 pathway activation is responsible for the detrimental inflammatory cytokine 
production that culminates in immunopathology (Sarangi et al., 2007; Wang et al., 2012). On 
the other hand, resistance to acute HSV-1 infection is mediated by p204 / IFN-inducible protein 
16 (IFI-16). CD Conrady et al suggested that recognition of HSV-1 by the innate cytoplasmic  
sensor (IFI-16) is the principal initiator of IFN production in the cornea. IFI-16 initiates IFN 
production through stimulator of interferon genes (STING) dependent manner (Conrady et al., 
2012). 
Recently, the interaction between DC and NK in the development of HSK has been under 
increased scrutiny. Frank et al have studied the role of dendritic cells as well as the interaction 
between DC and NK in the cornea during primary HSV-1 keratitis(Frank et al., 2012). He showed 
that DCs are necessary for optimal clearance of HSV-1 from the cornea. However, they assume 
this function by directing local NK cells which in turn, serve as the proximal mediator of viral 
clearance from the cornea(Frank et al., 2012).  
Herpes simplex encephalitis 
Herpes simplex virus is the most common cause of viral encephalitis worldwide (Aryee 
and Thwaites, 2015). Herpetic encephalitis is rare in immunocompetent individuals. In 
immunocompromised adult patients; primary or recurrent infection can result in encephalitis 
(Fatahzadeh and Schwartz, 2007). Of the 7.3 million hospitalizations for encephalitis in the US 
between 1979-1988, Herpes simplex virus accounts for 10% of the cases (Stahl et al., 2011a; 
Stahl et al., 2011b). Herpes simplex encephalitis has an incidence of 1 in 250,000–500,000 
individuals (Baringer, 2008; Whitley, 2006). If left untreated, herpes simplex encephalitis has a 
76 
 
70% fatality rate (Wald and Corey, 2007). Only 2.5 % of survivors returned to normal function, 
the remaining patients may sustain some degree of dysfunction (Whitley, 2006).  Ninety 
percent of herpetic encephalitis cases in adults are caused by HSV-1, whereas, HSV-2 is a more 
common cause of encephalitis in neonates (Ito et al., 2000). The virus gains access to the 
central nervous system (CNS) in primary infection through the olfactory and trigeminal nerves. 
Reactivation of a latent virus can lead to transport of virions to the CNS causing encephalitis 
(Whitley, 2006). The classical clinical presentation of herpetic encephalitis is headache, fever, 
neurologic deficits and altered mental state. However, these clinical signs are not 
pathognomonic (Whitley, 2006).  
At early stages of herpetic encephalitis, the brains of affected adults show bilateral, 
asymmetrical acute inflammation, congestion, and/or hemorrhage, most prominently in the 
temporal lobes. The meninges overlaying the affected areas appear congested or cloudy. After 
two weeks, the changes progress to liquefactive necrosis (Figure 2.18). Histologically, there is 
congestion of meninges and the cortex and subcortical white matter at early stages; however, 
at late stages (after two weeks), hemorrhagic necrosis, perivascular cuffing and glial nodules 
become evident. Inflammation consists of mononuclear infiltrates, gliosis and satellitosis and 
neuronophagia.  Found in only 50% of patients, intranuclear inclusion bodies are most often 
visible in the first week of infection. The intranuclear inclusion bodies (Cowdry type A 
inclusions) are characterized by an eosinophilic homogeneous appearance surrounded by a 
clear zone with marginated chromatin (Figure 2.19) (Booss and Kim, 1984; Kapur et al., 1994; 
Stahl et al., 2011a; Whitley, 2006). Cases of aseptic meninges are rare and the changes seen are 
mononuclear inflammatory cell infiltrates in the meninges and a slight increase in mononuclear 
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cell counts in the cerebrospinal fluid (CSF) (Dudgeon, 1969; Koskiniemi et al., 1980; Skoldenberg 
et al., 1984). Diagnosis of herpetic encephalitis relies on the presence of clinical signs, MRI 
imaging, PCR on brain biopsies and CSF, histopathological findings, serological tests (CSF) and 
viral isolation (Cinque et al., 1996; Whitley et al., 1989). 
 
Figure 2.18: Herpetic encephalitis. Bilateral asymmetrical necrohemorrhagic encephalitis, 
temporal and frontal lobes. Adapted from laboratory medicine, Yale school of medicine 
website; http://labmed.yale.edu/education/cme/casestudies/7/10.aspx. The website credits 
University of Iowa College of Medicine Virtual Hospital, Dr. Gary Baumbach, M.D., Department 
of Pathology, for the picture. 
 
 
Neonatal infections 
Infection of neonates with HSV can occur in utero (intrauterine), intrapartum and 
postpartum. Intrapartum infection constitute the most common mode of infection (75-80% of 
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the cases), whereas, postpartum infection accounts for approximately 10% of the cases (Brown 
et al., 2003). The majority of intrapartum neonatal infections are caused by HSV-2, however, 
HSV-1 infection may also occur (Roizman et al., 2007). Intrauterine infections are very rare, but 
they often have detrimental consequences such as disseminated cutaneous lesions and 
multiple developmental abnormalities including:  lissencephaly, microphthalmia and 
microcephaly to mention a few (Hutto et al., 1987; Roizman et al., 2007). 
         
Figure 2.19: Hematoxylin and eosin stained histological section of the brain. Intranuclear 
inclusion bodies (Cowdry type A inclusions) are characterized by an eosinophilic homogeneous 
appearance surrounded by a clear zone with marginated chromatin. Adapted from laboratory 
medicine, Yale school of medicine website;  
http://labmed.yale.edu/education/cme/casestudies/7/11.aspx. The website credits Dr. Peter 
Anderson, University of Alabama at Birmingham, Department of Pathology, for the image. 
 
There are estimated 1500 cases of neonatal infections with HSV per year in the US 
whereby the infection rate is 1 in 3000 births. Risk of transmission dramatically decreases with 
caesarean section delivery, or if the mother seroconverts before delivery (Brown et al., 2003; 
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Johnston et al., 2008). Neonatal infection with HSV can result in a wide range of clinical 
presentations including disseminated disease, central nervous system disease, or cutaneous 
disease. Forty five percent of neonatal infections involve the mouth, eye and skin. Thirty 
percent of the cases are central nervous system disease, and the disseminated disease accounts 
for the remaining 25% of the cases (Kimberlin, 2001; Kimberlin et al., 2001; Pinninti and 
Kimberlin, 2013a, b; Whitley, 1988). Although disseminated HSV disease has a higher mortality 
rate (29%) than CNS disease (4%), the frequency of disabilities is much lower. 69% of neonatal 
CNS disease cases suffer from disability and retarded brain development 1 year after the 
disease compared to 17% of disseminated disease cases (Pinninti and Kimberlin, 2013b).  
Symptoms of disseminated disease and CNS infection in neonates are not specific. The 
sings include; fever, anorexia, respiratory distress and lethargy. Disseminated disease in 
neonates involves the spread of the virus to multiple visceral organ systems (lungs, liver, eyes, 
skin, and brain) causing severe complications such as pneumonia, hepatitis, encephalitis and 
coagulopathy.  Central nervous system infection in neonates is similar to herpetic encephalitis 
in adults (Thompson and Whitley, 2011).   
Herpes simplex virus infection in immunocompromised patients 
Immunocompromised individuals are at a greater risk of severe, more common, and 
greater spread of primary or recurrent HSV infections. Impaired immune system function may 
occur due to metabolic disturbances and malnutrition, immunosuppressive therapy for cancer 
treatment or organ transplant, or acquired immunodeficiency syndrome (AIDS). The clinical 
manifestations of HSV infection in such patients ranges from vesicular dermatitis to esophagitis, 
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pneumonitis, colitis, and devastating systemic infections (Fatahzadeh and Schwartz, 2007; 
Roizman et al., 2007). More incidents of reactivation (60-95%) have been observed in 
immunosuppressed individuals (Arduino and Porter, 2008). It is noteworthy to mention that 
HSV-2 infection increases the risk of acquiring HIV by 2-4 folds. Also HSV-2-seropositive 
individuals have a 5-fold greater risk of acquiring HIV compared with HSV-2-negative individuals 
(Corey et al., 2004; Wald and Link, 2002). 
Prevention and Treatment of Herpes Simplex Infection 
Elimination of contact with seropositive individuals, the use of therapeutics and vaccines 
represent the main strategies to prevent and treat herpes virus infection. Preventative 
measures such as maintaining good hygiene, avoiding contact with infected individuals and 
using barrier methods during sexual activity such condoms would be ideal to eliminate contact 
with seropositive individuals. Unfortunately, this preventive measure is difficult to implement 
due to asymptomatic shedding. Seventy percent of HSV-1 infected persons shed the virus from 
the oral cavity at least once a month with many of the shedding incidents are without 
symptoms (Miller and Danaher, 2008).  
Anti-herpes virus therapeutic agents have been effective in reducing the duration of 
primary and recurrent infection as well as the symptoms. Acyclovir is effective against HSV-1, 
HSV-2, VZV and EBV (Kaye, 2009). It inhibits viral DNA polymerase activity and viral DNA 
synthesis. Acyclovir is a nucleoside analogue that mimics deoxyguanosine but lacks the 3’ 
hydroxyl moiety. In infected cells, viral thymidine kinase monophosphorylates acyclovir. 
Subsequently, cellular kinases convert acyclovir monophosphate to acyclovir triphosphate by 
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adding 2 additional phosphates. Acyclovir is incorporated in the growing DNA strand instead of 
deoxyguanosine triphosphate (dGTP). As a result, DNA polymerase is inhibited and DNA strand 
elongation is terminated (Coen, 2007; Wilson et al., 2009). Viral specificity of acyclovir is 
reflected in the fact that; 1) acyclovir is selectively phosphorylated by viral TK kinase at a higher 
efficiency than mammalian thymidine kinase, 2) acyclovir inhibits cellular DNA polymerase 
weakly compared to viral DNA polymerase (Kleymann et al., 2002) (Crumpacker and Schaffer, 
2002; Wilson et al., 2009). The emergence of acyclovir resistant HSV stains (approximately 6% 
of HSV isolates from HIV infected patients are acyclovir resistant), and the limited oral 
bioavailability of acyclovir pose significant problems. Therefore, alternatives to acyclovir have 
been researched in recent years. Foscarnet is a pyrophosphate analog that has been used as an 
alternative to acyclovir. Foscarnet inhibits viral DNA polymerase by preventing the release of 
pyrophosphate; a process required for DNA strand elongation. Foscarnet is used as the last 
resort because it is nephrotoxic and requires intravenous mode of administration. Valacyclovir, 
Famciclovir and Valganciclovir are nucleoside analogues with similar mode of action to 
acyclovir, but with improved oral bioavailability (Coen, 2007).  New classes of therapeutics such 
as aminothiazolylphenyl-containing drugs and thiazole urea derivatives have been 
experimentally shown to be promising drug alternatives for the treatment of HSV infections. 
These classes of drugs target helicase–primase complex rather than DNA polymerase. The new 
drugs increase the affinity of the primase and helicase subunits to DNA strands leading to the 
inhibition of viral DNA synthesis (Crumpacker and Schaffer, 2002; Kleymann et al., 2002) (Crute 
et al., 2002).  
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Many experimental drugs such as glycosylation inhibitors and plant extracts such as Aloe 
vera, Swertia chirata and Melissa officinalis, and Toll like Receptor agonists have been 
examined for their efficacy and toxicity to be used as anti-herpesvirus therapeutics. Some of 
those compounds have shown promising preliminary results.  
The goal of development of vaccine therapeutics to HSV is to augment immune 
responses against it and to suppress recurrences. HSV vaccine strategies include the 
construction of genetically attenuated live virus vaccines, killed or inactivated virus vaccines, 
recombinant subunit vaccines, DNA vaccines as well as immunizations with replication 
competent and replication incompetent vectors. An example of a recently constructed 
genetically modified attenuated live virus vaccine is ACAM529. ACAM529 is an anti-HSV-2 
vaccine that has been optimized for commercial manufacturing (Sanofi Pasteur) and is currently 
under phase I clinical trials. This vaccine has shown both strong immunogenicity and high 
efficacy in vivo (Mundle et al., 2013). Promising results have been observed with HSV-2 live-
attenuated ICP0 deletion virus (ICP10DPK) which showed prevention of recurrent disease in 
37% and 43.5% of vaccinated individuals in two separate trials (Casanova et al., 2002). Lupidon 
H and lupidon G is a whole heat-inactivated virus from HSV-1 and HSV-2, respectively. This 
vaccine was shown to reduce incidents of recurrences; however, the results were inconclusive 
due to lack of use of proper controls (Weitgasser, 1977). An experimental HSV-2 subunit 
vaccine (GEN-003/MM-2) composed of HSV-2 gD2 and a truncated form of ICP4 prepared with 
Matrix M-2 (MM-2) adjuvant was able to elicit humoral immune responses, CD4(+) and CD8(+) 
T cells resulting in decreased recurrent disease symptoms and reduced the frequency of 
recurrent viral shedding in Guiana pigs (Skoberne et al., 2013). Lipopeptide vaccines represent a 
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new strategy in vaccine development; the preparations are made for mucosal topical ocular 
and intravaginal application. The principle is predicated on the recent findings that HSV 
protective epitopes are recognized by T cells from symptomatic individuals versus 
asymptomatic (Dasgupta et al., 2009).  Recent work in this laboratory has shown that a single 
vaccination using a recombinant virus with a mutation in gK and UL20 conferred 100% 
protection against lethal challenge with HSV-1 and HSV-2 wild type viruses (Stanfield et al., 
2014) . This vaccine is currently being tested by the National Institute of Allergy and Infectious 
Diseases (NIAID), Vaccine and Treatment Evaluation Units (VTEUs) in Cincinnati. 
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CHAPTER III: FUNCTIONAL HIERARCHY OF HERPES SIMPLEX VIRUS TYPE-1 (HSV-
1) MEMBRANE PROTEINS IN CORNEAL INFECTION AND VIRUS TRANSMISSION 
TO GANGLIONIC NEURONS * 
Introduction 
Ocular herpes simplex virus (HSV) infection is one of the most common infectious 
causes of blindness in developed countries. Moreover, frequent reactivation of latent virus can 
cause recurrent herpes keratitis and corneal graft failure (Cockerham, 2001; Cockerham et al., 
1997; De Kesel et al., 2001; Liesegang, 2001; Liesegang et al., 1989; Tullo, 2003). Typically, 
primary infection of epithelial cells exposed on orofacial mucocutaneous tissues leads to 
invasion of embedded axonal termini embedded within the cornea via fusion of the viral 
envelope with neuronal synaptic membranes. Subsequently, capsids are transported in a 
retrograde manner to neuronal cell somata where viral genomes can establish life-long latency 
(Antinone and Smith, 2010).  Infrequently and particularly in newborn infections, neuronal 
infection can cause acute encephalitis and significant morbidity and mortality (Fatahzadeh and 
Schwartz, 2007).  Immunosuppression as well as other external stimuli can cause reactivation of 
the virus from the latent state and re-infection of peripheral tissues including corneas and 
orofacial surfaces (Smith, 2012).  
 
 
 
* This chapter previously appeared as Kim IJ & Saied AA, Chouljenko VN, Subramanian R, 
Kousoulas KG, Functional hierarchy of herpes simplex virus type-1 membrane proteins in 
corneal infection and virus transmission to ganglionic neurons. Curr Eye Res, 2014. 39(12): p. 
1169-77. It is reprinted by permission of the Informa Healthcare. Saied AA is co-first author. 
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Virion entry into all cells including neurons involves viral glycoproteins gD, gB, gH, gL, 
and gC (Connolly et al., 2011).  HSV-1 enters neuronal cells via a pH-independent fusion of the 
viral envelope with neuronal axonal membranes (Nicola et al., 2005; Qie et al., 1999), while it 
can enter a wide range of non-neuronal cells via either pH-independent or pH-dependent 
endocytosis (Milne et al., 2005). Retrograde transport of capsids to neuronal somata after 
infection of axonal termini is mediated by the dynein motor in conjunction with the neuronal 
microtubular network (Diefenbach et al., 2008; Johnson and Baines, 2011; Mettenleiter et al., 
2009). Glycoprotein gB is thought to be the sole fusogenic glycoprotein, while glycoproteins gD 
and gH/gL are required to activate gB’s fusogenicity in conjunction with specific cellular 
receptors (Connolly et al., 2011). Binding of gD to its cognate receptors including nectin-1, 
HVEM, and other receptors (Campadelli-Fiume et al., 2000; Geraghty et al., 1998; Montgomery 
et al., 1996; Satoh et al., 2008; Shukla et al., 1999; Spear et al., 2000; Spear and Longnecker, 
2003) triggers sequential conformational changes in gH/gL and gB causing fusion of the viral 
envelope with cellular membranes during virus entry, as well as during virus-induced cell-to-cell 
fusion (Hannah et al., 2007; Heldwein et al., 2006). 
Wild-type virus strains typically cause limited but measurable amount of cell-to-cell 
fusion in cell culture (Kousoulas et al., 1978). However, most viral lesions in human and animal 
tissues are characterized by the presence of multinucleated cells (syncytia) (Goldgeier et al., 
2002; Roizman et al., 2007). Virus-induced cell-fusion is an important mechanism for virion 
transmission to adjacent cells without exposure to the host humoral immune system, 
particularly neutralizing antibody [reviewed in reference(Roizman et al., 2007)].  Extensive 
membrane fusion can be induced by co-expressing glycoproteins gB, gD and gH/gL in cell lines 
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indicating that gB, gD, and gH/gL are essential components for both virus entry and virus-
induced cell fusion. (Muggeridge, 2000; Turner et al., 1998). Additional viral genes encode 
proteins that have been shown to be involved in virus-induced cell fusion without necessarily 
drastically affecting virus entry kinetics. These genes include: the UL20 gene (Baines et al., 
1991; McLean et al., 1990; Melancon et al., 2004), the UL24 gene (Jacobson et al., 1998; 
Sanders et al., 1982), and the UL53 gene coding for gK (Bond and Person, 1984; Debroy et al., 
1985; Hutchinson et al., 1992; Pogue-Geile et al., 1984; Pogue-Geile and Spear, 1987; Ruyechan 
et al., 1979).  Also, certain mutations within the UL27 gene encoding glycoprotein gB drastically 
enhance virus-induced cell-fusion presumably because they destabilize the virus-encoded 
fusion machinery (Bzik et al., 1984; Pellett et al., 1985).  We have shown that lack of either 
glycoprotein gK or the membrane protein UL20 severely inhibits membrane fusion (Melancon 
et al., 2004; Melancon et al., 2005). Moreover, we have shown that HSV-1 gK and UL20 
functionally and physically interact and that these interactions are absolutely necessary for 
their coordinate intracellular transport, cell-surface expression and membrane fusion functions 
in the HSV-1 life cycle (Chouljenko et al., 2009; Chouljenko et al., 2010; Foster et al., 2001).  
Glycoproteins gM and gE and the membrane-associated UL11 protein have been also 
implicated in virus-induced cell fusion and virion egress (Chouljenko et al., 2012; Kim et al., 
2013).  Glycoprotein gM is a conserved type III integral membrane protein with multiple 
transmembrane domains, that forms a complex with pUL49.5 (gN) [reviewed in (Roizman et al., 
2007)]. Deletion of the gM gene does not abrogate HSV-1 replication, but does affect the ability 
of the virus to spread (Leege et al., 2009). Expression of HSV-1, pseudorabies (PRV) and Kaposi 
sarcoma associated herpesvirus (KSHV or HHV-8) gM and gN in transfected cells inhibited cell 
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fusion caused by simultaneous expression of gB, gD, gH and gL glycoproteins (Klupp et al., 2000; 
Koyano et al., 2003). Also, lack of gM was reported to inhibit virus-induced cell fusion caused by 
a single amino acid substitution in the carboxyl terminus of gB (A855V; gBsyn) (Balan et al., 
1994). HSV-1 glycoprotein gE is expressed as a heterodimer with gI and functions to facilitate 
cell-to-cell spread by sorting newly formed virion particles to cell junctions and lateral cell 
surfaces (Collins and Johnson, 2003). Unlike PRV, HSV-1 gE-null viruses exhibited a retrograde 
spread defect in vivo but not in vitro (McGraw et al., 2009).  UL11 is a 96-amino-acid 
myristoylated and palmitoylated tegument protein anchored into the cytoplasmic side of cell 
membranes (Baines et al., 1995; Baird et al., 2008; Loomis et al., 2001; MacLean et al., 1989). 
UL11 interacts with viral glycoprotein gE and tegument proteins UL16 and UL21 and has been 
suggested to play a role in recruiting viral proteins to the virion assembly site at the trans-Golgi 
network (TGN) (Baird et al., 2008; Farnsworth et al., 2007; Han et al., 2012; Leege et al., 2009; 
Loomis et al., 2001; Loomis et al., 2003). Although absence of UL11 in HSV-1 and PRV revealed 
only moderate defects in viral replication (Chouljenko et al., 2012; Fulmer et al., 2007; Kopp et 
al., 2003; Leege et al., 2009), the HCMV UL11 homologue is essential for virus replication (Seo 
and Britt, 2007; Silva et al., 2003).  
Recently, we showed that lack of either the gK or UL20 gene expression produced 
significantly greater defects in virion envelopment and overall virus replication than deletion of 
either the carboxyl terminus of gD, or lack of either UL11, gM or gE gene expression alone or in 
various combinations (Chouljenko et al., 2012). Herein, we investigated the in vivo effects of 
lack of either gE, gM, gK or UL11 using the scarified mouse eye HSV-1 infection model.  The gK-
null virus was unable to efficiently infect neurons and establish latency, in contrast to all other 
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mutant viruses. Surprisingly, although the UL11-null virus replicated less efficiently mouse 
corneas, it infected ganglionic neurons with greater efficiency than the gM and gE-null viruses. 
These results suggest that in the scarified mouse eye model system, replication in the eye is not  
directly associated with ability to infect neuronal endings and establish latency in ganglionic 
neurons. Moreover, gK serves more important functions in neuronal infection than either gM, 
gE or the UL11 protein.  
Materials and Methods 
Cells and viruses 
African green monkey kidney (Vero) cells were obtained from the American Type 
Culture Collection (Rockville, MD) and grown and propagated in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 5-10% fetal bovine serum (FBS) and antibiotics. The gK-
complementing VK302 cell line (generously provided by David Johnson, Oregon Health Sciences 
University, Portland, OR) was maintained in DMEM supplemented with 10% FBS and antibiotics. 
The HSV-1(F) cloned as a bacterial artificial chromosome was a gift from Dr. Kawaguchi 
(Chouljenko et al., 2012; Lee et al., 2009; Tanaka et al., 2003; Tischer et al., 2006). All viruses 
were grown on Vero cells and equal PFU were used for all viruses in the ocular infection 
experiments. The gK-null virus was tittered on the VK302 complementing cell line. 
Construction and characterization of recombinant viruses 
The recombinant viruses were constructed in previous studies (Chouljenko et al., 2012; 
Kim et al., 2013; Melancon et al., 2005).  Briefly, mutagenesis was performed in E. coli using 
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two-step red mutagenesis implemented on HSV-1(F) strain cloned into the bacterial artificial 
chromosome plasmid vector pYEbac102, as described previously (Kim et al., 2013). The gM-null 
virus was constructed by altering two potential initiation codon sites (from ATG to CTG and from 
ATG to ATT). The UL11-null and gE-null viruses were constructed by changing their respective 
initiation codons from ATG to CTG, as described in detail previously (Kim et al., 2013) . The gK-
null virus was constructed by replacing gK with a GFP-zeo gene cassette (Melancon et al., 2005).  
All recombinant viruses were sequenced using next generation sequencing (NGS) to confirm the 
introduction of the intended mutations and the absence of collateral unwanted nucleotide 
changes, as described earlier (Kim et al., 2013). 
Plaque morphology and viral yields of wild-type and mutant viruses 
Confluent monolayers of Vero and VK302 cells were infected with WT BAC, ∆gM, ∆gE, 
∆gK, ∆UL11 viruses at MOI of 0.001. Cells were fixed by methanol at 48 hpi.  After fixation, 
immunohistochemistry was performed using a horseradish peroxidase conjugated goat-anti-
rabbit antibody (Dako Carpinteria, CA). The reactions were developed using NovaRed substrate 
(VectorLabs, Burlingame, CA, USA).  Viral yields were obtained essentially as described 
previously (Saied et al., 2013). Briefly, confluent monolayers of Vero cells were infected with 
WT BAC, ∆gM, ∆gE, ∆gK, ∆UL11 viruses at MOI of 0.1. Infections were halted by freezing at 0, 
24, and 48 hpi. Plates were prepared in triplicates and viral titers were determined for each 
time point by standard plaque assay. Plaques were stained by immunohistochemistry and 
visualized using dissecting microscope.  
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Ocular infections 
Balb/c mice were used for all experiments and were handled in accordance with the 
ARVO statement for the use of animals in ophthalmic and vision research and Louisiana State 
University-School of Veterinary Medicine IACUC regulations. Corneal scarification and ocular 
inoculation of mice were performed as described previously (David et al., 2008; Saied et al., 
2014).  Briefly; female Balb\c mice were divided into 6 groups; each group was inoculated with 
either WT BAC, ∆gM, ∆gE, ∆gK, ∆UL11 viruses, or a mock-infected. After anesthesia, 25-26 G 
needle was used to scarify mice corneas in a grid like pattern (4 cross hatches per eye). 
Infections were performed using 105 PFU for each virus applied to each eye by a micropipette. 
After inoculation, the eyelids were gently held shut for a few seconds. Clinical ocular changes 
were monitored daily for keratitis, blepharoconjunctivitis and ocular discharge.  Mice eyes were 
rinsed at 24, 48 and 72 hours post infection and the number of infectious virions within the 
rinsing solution was determined by plaque assay. 
Quantitative PCR (qPCR) analysis 
Trigeminal ganglia (TG) were collected 30 days post infection (dpi) for qPCR analysis and 
stored at -80 °C. After thawing, Qiagen DNeasy blood and tissue kit (Qiagen, Valencia, CA) was 
used to extract total DNA from the TG per manufactures instructions. QPCR was performed as 
initially described previously for Kaposi’s sarcoma herpesvirus (KSHV) (Subramanian et al., 
2008; Subramanian et al., 2010) and utilized for HSV-1 DNA detection in neuronal cell cultures 
(Kim et al., 2013). Briefly, the primers and probe (6-carboxytetramethylrhodamine (TAMRA) for 
the real-time PCR were designed to detect HSV-1 US6 (gD).  The amount of DNA extracted from 
116 
 
each trigeminal ganglion was measured using Nanodrop spectrophotometer (Thermo Scientific, 
Wilmington, DE). Total DNA concentration from each ganglion was approximately 80 ± 5 mg per 
ganglion. Equal volumes of viral DNA were used for qPCR analysis. Purified plasmid containing 
the gD gene was used to generate the standard curve. 
Results 
Comparison of the replication characteristics of recombinant viruses lacking gM, gE, UL11, or 
gK.   
The gM-null, UL11-null and gE-null (Figure 1) viruses were constructed previously via 
mutagenesis of their respective initiation codons utilizing the cloned HSV-1(F) genome into a 
bacterial artificial chromosome (WT BAC), while the gK-null was constructed via gene 
replacement mutagenesis (Figure 1) (see ‘‘Materials and methods’’ section). The gK-null virus 
formed very small plaques on Vero cells, while it was efficiently complemented and formed 
much larger plaques on the VK302 cell lines expressing gK (Figure 2). The gE and gM-null viruses 
produced viral plaques that on average were approximately 50% smaller, while the UL11-null 
virus produced viral plaques that were approximately 75% smaller than the wild-type virus 
(Figure 2). The replication kinetics of the gM and UL11-null viruses were similar yielding final 
titers that were approximately one log less than the wild-type virus at 48 hpi. The gE-null virus 
replicated with similar kinetics to the wild-type virus, while the gK-null virus replicated very 
inefficiently yielding final titers that were at least three logs less than the wild-type virus at 48 
hpi (Table 3.1).  
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Figure 3.1: Schematic representation of mutant viruses. The top line represents the prototypic 
arrangement of the HSV-1 genome with the unique long (UL) and unique short (US) regions 
flanked by the terminal repeat (TR) and internal repeat (IR) regions. IGR denotes the intergenic 
region. The relevant genome regions of the parental wild-type HSV-1(F) genome cloned as a bac 
(WT BAC) and the gM, gE, and UL11-null viral genomes are shown. *Denotes mutagenesis of 
initiation codons that prevent gene expression. The gK-null virus was constructed by replacing 
the UL53 gene that encodes gK with a GFP-Zeo gene cassette under the control of the 
cytomegalovirus IE promoter (CMV)(Melancon et al., 2005). 
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Figure 3.2: Plaque morphology of mutant viruses. Confluent monolayers of Vero or VK302 cells 
were infected at an approximate MOI of 0.001 and representative plaques were identified as 
indicated by immunohistochemistry staining. Viral plaques were photographed at the same 
magnification. VK302 is a cell line expressing gK upon infection. 
 
Table 3.1: Comparison of viral yields between wild type and recombinant viruses:  
Table 3.1 shows viral yields in plaque forming units (PFU)/ml. Hours post infection (HPI). 
Triplicate samples were titrated and the standard error of mean at each time point was 
calculated. 
Mouse eye infections 
Mouse corneas were scarified and infected with 105 PFU in each eye. Clinical ocular 
changes were monitored daily for the development of blepharoconjunctivitis, keratitis and 
ocular discharge. Mice infected with the wild-type virus exhibited mild-clinical symptoms at 7 
dpi, while none of the mice infected with the mutant viruses exhibited any significant ocular 
Virus\HPI 0 HPI 24 HPI 48 HPI 
WT BAC 8.67x101 ± 6.67x101 4.87x107 ± 8.19x106 6x107 ± 2x107 
gE-null 3.33x101 ± 1.76x101 4.93x107 ± 4.67x106 8.667x107 ± 1.764x107 
gM-null 3.33x101 ± 1.33x101 9.33x106 ± 3.33x106 1.13x107 ± 1.76x106 
UL11-null 3.33x101 ± 6.67 8.07x106 ± 8.82x105 1.13x107 ± 4.05x106 
gK-null 6.67x101 ± 4.80x101 1.13x104 ± 3.52x103 2.47x104 ± 1.27x104 
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changes (Figure 3.3). Viral shedding was determined daily up to 72 hpi daily. The wild-type virus 
produced the highest viral titers in eyewashes, followed by the gM-null, gE-null, UL11-null and 
gK-null (Figure 3.4).  
 
Figure 3.3: Clinical ocular disease development. Representative pictures of infected eyes are 
shown. Mice eyes were monitored for the development of blepharoconjunctivitis, hyperemia, 
keratitis and ocular discharge (A) WT BAC group, notice the blepharitis; thickening of upper and 
lower eyelids (arrows). (B) gM-null group. (C) gE-null group. (D) UL11-null group. (E) gK-null 
group (F) Mock group. 
 
Determination of viral DNA in trigeminal ganglia of infected mice 
The TG harboring latent viral DNA were collected from mice at 30 dpi and were tested 
for the presence of viral DNA genomes by qPCR, as we have described previously (David et al., 
2012; Saied et al., 2013). On average, approximately 11,200 viral DNA genomes were detected 
per single TG of mice infected with the wild-type virus. Viral genomes were detected in the TGs 
of mouse infected with all mutant viruses except the gK-null-infected mice. Specifically, 2-of-10 
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mice infected with the gM-null virus contained on average 600 viral genomes, 4-of-10 mice 
infected with the gE-null virus contained on average 600 viral genomes, and 6-of-10 UL11-null-
infected mice contained on average 2400 viral genomes. The numbers of viral genomes 
recovered from the wild-type infections were significantly different in comparison to all mutant 
viruses by one-way ANOVA test (Figure 3.5). 
           
Figure 3.4: Viral shedding. Viral titers were obtained from eye rinses obtained at 24, 48 and 72 
hpi. DgK and Mock values are zeros.  
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Figure 3.5: Viral DNA genome detection by qPCR. Equal volumes of viral DNA were used for 
TaqMan PCR. Purified plasmid containing the gD gene was used to generate the standard curve. 
 
Discussion 
We have demonstrated previously that HSV-1 gK plays a pivotal role in neuronal 
infection. Specifically, lack of gK prevents infection of TG after infection of scarified mouse eye 
corneas, and inhibits retrograde and anterograde translocation of virions via neuronal axons 
(David et al., 2008; David et al., 2012). The purpose of the present investigations was to 
compare and contrast the ability of mutant viruses lacking gK, gM, gE, or UL11to productively 
infected mouse corneas and ganglionic neurons in vivo and establish latency in the TG. Our 
results confirm previous findings that lack of gK causes severe reduction in the ability of the 
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virus to infect corneal cells and neurons despite the direct exposure of neuronal endings after 
cornea scarification. In contrast, viruses lacking either gM, gE or UL11 infected mouse corneas 
and established latent infections. Importantly, although the UL11-null virus replicated 
inefficiently in mouse eyes, it infected ganglionic neurons and established latency more 
efficiently than either the gM or gE-null viruses. 
The wild-type HSV-1(F) virus produced only mild ocular changes after infection of mouse 
eyes characterized by mild blepharoconjunctivitis only at late times post infection (7 days). 
These results are significantly different to our previous findings that the HSV-1(McKrae) strain 
produce drastic ocular changes marked by severe blepharitis, hyperemia, keratitis and high 
ocular discharge 7-8 days post infection (Saied et al., 2014). The HSV-1(F) infection results are 
consistent with previous findings that this viral strain was relatively apathogenic after 
intracranial infection of mouse brains (Sedarati and Stevens, 1987). Moreover, the HSV-1(F) 
strain utilized in the present investigations was recovered from the bac-cloned HSV-1(F) 
genome (pYE102). Thus, it is possible that incorporation of the bac plasmid within the viral 
genome contributed to the observed lack of ocular immunopathogenicity. The genomic 
sequences of the HSV-1(F), KOS and McKrae strains have been obtained (Macdonald et al., 
2012a, b; Szpara et al., 2010). Alignment of the HSV-1(F) and McKrae genes encoding viral 
glycoproteins reveals multiple single amino acid changes (Chowdhury et al., 2012). Additional 
changes are predicted in many other genes when McKrae and F strains are compared (not 
shown). One or more of these predicted amino acid changes may be responsible for the 
observed ocular pathogenetic differences between these two viral strains. 
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Mouse corneas contain over 50,000 neuronal axonal termini per mm2. Therefore, cross-
hatching scarification exposes neuronal endings to direct viral infection. In this regard, cornea 
scarification provides a model for assessing the ability of viruses to directly infect ganglionic 
neurons through their axonal termini. Using this model, we showed previously that lack of gK 
drastically impaired the ability of the virus to infect ganglionic neurons and establish latency. In 
this article, we confirm these findings and compare them to the ability of gM-, gE-, and UL11-
null viruses to infect ganglionic neurons. All three mutant viruses were able to infect ganglionic 
neurons, albeit at reduced frequencies in comparison to the parental HSV-1(F) strain. These 
results suggest that gM, gE and UL11 serve potentially secondary roles in corneal ganglionic 
neuronal infections in comparison to gK.  Surprisingly, although the UL11-null virus replicated 
less efficiently in Vero cell monolayers and mouse eyes, it infected ganglionic neurons more 
efficiently than the gM-null or gE-null viruses. This result supports our hypothesis that ocular 
viral replication may contribute, but not serve the most important role in infection of ganglionic 
neurons in the scarified mouse eye infection model system.  
Recently, we showed that gM interacts with the gK/UL20 protein complex and that UL11 
is required for virus-induced cell fusion caused by syncytial mutations in gB or gK, respectively 
(Kim et al., 2013). Thus, the absence of either gM or UL11 from the virion particle may perturb 
gB and gK/UL20 fusogenic functions preventing efficient entry into neuronal axons embedded 
within scarified mouse corneas. Additional work is needed to directly demonstrate potential 
defects in axonal cytoplasmic entry for these viruses. These experiments are currently in 
progress.  
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CHAPTER IV: A REPLICATION COMPETENT HSV-1(MCKRAE) WITH A MUTATION 
IN THE AMINO-TERMINUS OF GLYCOPROTEIN K (GK) IS UNABLE TO INFECT 
MOUSE TRIGEMINAL GANGLIA AFTER CORNEA INFECTION* 
Introduction 
HSV-1 causes multiple medical disorders such as cold sore, keratitis, encephalitis and 
systemic disease (Whitley et al., 1998).  The hallmark of the HSV-1 life cycle is infection of 
sensory neurons, where the virus establishes a latent infection for the life of the host (Roizman 
et al., 2007; Whitley et al., 1998).  HSV-1 primary infection starts at the mucocutaneous surface 
and then the virus invades the axonal termini to undergo retrograde transport to neuronal cell 
body (Antinone and Smith, 2010).  Upon, reactivation of the virus from the latent state, the 
virus transports in anterograde manner to the periphery (Smith, 2012).  
Ocular HSV is one of the most common infectious causes of blindness in developed 
countries with estimates of the incidence of herpes ocular disease episodes ranging from 4.1 to 
20.7 cases per 100,000 in developed countries.  In the United States, approximately 500,000 
people suffer from herpes simplex ocular disease (Liesegang, 2001; Liesegang et al., 1989).  A 
nationwide prospective study in France conducted in 2002 estimated the incidence of herpes 
keratitis to be 25.8 cases per 100,000 persons annually (Labetoulle et al., 2005). Recurrent 
herpes keratitis leads to corneal opacity and vision loss.  Also, reactivation of latent virus from 
the trigeminal ganglia (TG) can cause spread to corneal transplants causing corneal graft failure 
(Cockerham, 2001; Cockerham et al., 1997; De Kesel et al., 2001; Tullo, 2003). 
* This chapter previously appeared as Saied AA, Chouljenko VN, Subramanian R, Kousoulas KG.,
A replication competent HSV-1 (McKrae) with a mutation in the amino-terminus of glycoprotein 
K (gK) is unable to infect mouse trigeminal ganglia after cornea infection. Curr Eye Res, 2014. 
39(6): p. 596-603. It is reprinted by permission of Informa Healthcare.   
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HSV-1 enters neuronal cells via a pH-independent fusion of the viral envelope with 
neuronal plasma membranes (Nicola et al., 2005; Qie et al., 1999), while it can enter a wide 
range of non-neuronal cells via either pH-independent or pH-dependent endocytosis (Milne et 
al., 2005). Virus entry into all cells involves the coordinated functions of the glycoproteins gD, 
gB, gH, gL, and gC (Connolly et al., 2011).  Fusion of the viral envelope with cellular including 
neuronal membranes causes deposition of the viral capsid into the cytoplasm, which is 
subsequently transported to the cell nucleus. Retrograde transport of capsids to neuronal 
somata after infection of axonal termini is highly dependent on the cellular microtubule 
network and is most likely mediated via direct interactions by one or more tegument and 
capsid proteins with the dynein motor and the dynein cofactor dynactin (Diefenbach et al., 
2008; Johnson and Baines, 2011; Mettenleiter et al., 2009). 
The UL20 and UL53 (gK) genes are highly conserved in all alpha herpesviruses and 
encode proteins of 222 and 338 amino acids, respectively, each with four membrane spanning 
domains (Debroy et al., 1985; Foster et al., 2003; MacLean et al., 1991; Melancon et al., 2004; 
Ramaswamy and Holland, 1992).  The amino and carboxyl termini of gK are located 
extracellularly, while the amino and carboxyl termini of UL20 are located intracellularly (Foster 
et al., 2003; Melancon et al., 2004).  gK is post-translationally modified by N-linked 
carbohydrate addition at the amino-terminus of gK, while the UL20 protein (UL20p) is not 
glycosylated (Debroy et al., 1985; Hutchinson et al., 1992; Ramaswamy and Holland, 1992).  
HSV-1 gK is a structural component of virions and it interacts with UL20p on virion and cellular 
membranes.  HSV-1 gK and UL20 interaction is required for their coordinated intracellular 
transport, cell surface expression, and functions in virus-induced cell fusion, virus entry, virion 
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envelopment and egress from infected cells (Foster et al., 2003; Foster et al., 2008; Foster and 
Kousoulas, 1999; Foster et al., 2004a; Foster et al., 2001a; Foster et al., 2004b; Hutchinson et 
al., 1995; Jambunathan et al., 2011; Jayachandra et al., 1997).  The amino terminus of gK 
interacts with gB and gH and can complement gB-mediated cell fusion indicating that the 
gK/UL20 protein complex can modulate virus entry and virus-induced cell fusion via modulating 
gB and gH membrane fusion functions (Chouljenko et al., 2009; Chouljenko et al., 2010).  
Virions that lack gK enter into African monkey kidney cells (Vero), albeit with lower 
efficiency than the wild-type virus (Foster et al., 2001b; Jambunathan et al., 2011).  Deletion of 
amino acids 31-68 within the amino terminus of gK inhibits virus-induced cell-to-cell fusion and 
virus entry without drastically inhibiting virion envelopment and egress.  Specifically, a 
recombinant virus lacking gK amino acids 31-68 replicated fairly efficiently, while gK deletions 
from amino acids 31-47 and 31-117 exhibited major defects in infectious virus production 
(Chouljenko et al., 2009).  However, deletion of gK amino acids 31-68 inhibited virus-induced 
cell fusion caused by syncytial mutations in gK and entry into PILR-alpha expressing Chinese 
hamster ovary cells (Chouljenko et al., 2009; Chowdhury et al., 2013).  We have shown that gK 
is essential for neuronal infection and virulence (David et al., 2008).  Specifically, we have 
reported that gK-null virus was unable to infect axonal termini and egress from neuronal cell 
bodies (David et al., 2012).  
To further investigate the role of gK in neuroinvasiness, we engineered the gK 31-68 
amino acid deletion in the HSV-1(McKrae) genome cloned as a bacterial artificial chromosome 
(McK). In vivo experiments utilizing the mouse eye model system revealed that this virus was 
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unable to efficiently infect mouse TG after ocular infection of scarified mouse eyes.  These 
results indicate that the amino terminus of gK plays pivotal role in corneal infection, 
neuroinvasiveness and acute herpes keratitis.  
Materials and Methods: 
Cells and viruses  
African green monkey kidney (Vero) cells were obtained from the American Type 
Culture Collection (Rockville, MD) and grown in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 5-10% fetal bovine serum (FBS) and antibiotics. The gK-complementing 
VK302 cell line (generously provided by David Johnson, Oregon Health Sciences University, 
Portland, OR) was maintained in DMEM supplemented with 10% FBS and antibiotics. The 
clinical ocular isolate and the neuroinvasive strain of HSV-1 (McKrae) was a gift from J. M. Hill 
(Louisiana State University Health Sciences Center, New Orleans, LA). 
Construction and characterization of recombinant viruses 
The McKrae strain of HSV-1 was originally cloned into a bacterial artificial chromosome 
(BAC) vector. The construction methodology for mutant viruses for this experiment is 
essentially similar to the techniques that were previously described (Chowdhury et al., 2013; 
Tanaka et al., 2003). Briefly, the BAC plasmid PBeloBAC 11 (NEB) was inserted between the UL3 
and UL4 viral genes. An excisable EGFP cassette bracketed by flippase recognition target (FRT) 
sequences was cloned into the BAC plasmid vector.  Vero cells were transfected with the 
plasmid vector and infected with HSV-1 (McKrae) virus. Fluorescent plaques were selected and 
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the presence of BAC plasmid was confirmed by PCR-assisted DNA sequencing (Chowdhury et 
al., 2013). The recombinant virus McK∆gK31-68 was constructed by deleting 38 amino acids (gK 
amino acids 31- 68) from the amino terminus of gK as described previously for the HSV-1 (F) 
genome cloned into BAC plasmid pYEbac102 (Tischer et al., 2006).  During the construction of 
this virus the EGFP gene is spontaneously removed via FRT-mediated recombination. A rescued 
virus was also produced by transfection of a gene segment spanning the gK gene followed by 
infection with a gK mutant virus. All viruses were sequenced using the Ion Personal Genome 
Machine (PGM) sequencer (Life Technologies-Invitrogen, Carlsbad, CA) to confirm the ∆gK31-68 
deletion and the absence of any other nucleotide changes within coding sequences. 
Plaque morphology and replication kinetics of wild-type and mutant viruses 
For plaque size and morphology, confluent monolayers of Vero and VK302 cells were 
infected with McK, McKR (rescued virus), or McK∆gK31-68 viruses at MOI of 0.001.  Cells were 
fixed by methanol at 48 hpi.  After fixation, immunohistochemistry was performed using a 
horseradish peroxidase conjugated goat-anti-rabbit polyclonal antibody (Dako Carpinteria, CA).  
The reactions were developed using NovaRed substrate (VectorLabs, Burlingame, CA, USA).  
Replication kinetics were determined as described previously (David et al., 2008; David et al., 
2012). Briefly, confluent monolayers of Vero cells were infected with McK, McKR, or McK∆gK31-
68 viruses at MOI of 1.  Infections were stopped by freezing at 0, 6, 12, 18 and 24 hours post 
infection (hpi).  Plates were prepared in triplicates and viral titers were determined for each 
time point by standard plaque assay.  Plaques were stained by immunohistochemistry and 
visualized using a dissecting microscope.  
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Animals 
Female BALB\c mice (6-to-10-week-old) were divided into four groups; each group was 
infected with McK, McKR, McK∆gK31-68 viruses, or mock-infected.  All animals were handled in 
accordance with the ARVO statement for the use of animals in ophthalmic and vision research 
and Louisiana State University-School of Veterinary Medicine IACUC regulations. Animals were 
anesthetized, and the corneas were scarified in a grid pattern using a 25-26 G needle as 
described previously (David et al., 2008).  Each eye was inoculated with 105 plaque forming 
units (pfu) applied using a micropipette.  After inoculation, the eyelids were gently held shut for 
a few seconds.  The clinical ocular disease development and progression were monitored and 
scored daily.  The scoring criteria included the degree of blepharoconjuctivitis, hyperemia, 
keratitis and ocular discharge. The ocular disease was scored on a scale of 0-3. Zero 
represented a normal eye with no clinical symptoms, and 3 represented severe clinical 
presentation of the ocular changes.  
Quantitative PCR analysis 
TG were collected 30 days post infection (dpi) for quantitative PCR (qPCR) analysis and 
stored at -80° C.  After thawing, trigeminal ganglia were processed using the Qiagen DNeasy 
blood and tissue kit (Qiagen, Valencia, CA) to isolate total DNA per the manufacturer’s 
instructions. qPCR was performed as initially described previously for Kaposi’s sarcoma 
herpesvirus (KSHV) (Subramanian et al., 2008; Subramanian et al., 2010) and subsequently 
utilized for HSV-1 DNA detection in neuronal cell cultures (David et al., 2012). Briefly, the 
primers and probe (6-carboxytetramethylrhodamine (TAMRA) for the real-time PCR were 
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designed to detect the HSV-1 US6 (gD).  Equal amounts of total DNA were used for TaqMan PCR 
analysis.  A baseline cutoff value of 0 was set at approximately 50 genomes, since samples 
containing less than 50 genomes exhibited high variability among the triplicate samples.  
Purified plasmid containing the gD gene was used to generate standard curves as described 
previously (David et al., 2012).  
Infectious viral particle recovery 
TG explants were collected from mice 30 dpi and were incubated at 37° C and 5% CO2 
immersed in DMEM media with no FBS for 48 hrs. Then, ganglia explants were macerated and 
co-cultured with Vero cells for another 48 hrs. Virus stocks were prepared and the number of 
infectious virions was determined by standard plaque assay. 
Results 
Construction and characterization of recombinant viruses 
Construction and characterization of the McK virus was described previously 
(Chowdhury et al., 2013).  This virus has a bac containing a EGFP gene cassette inserted within 
the intergenic region between the UL3 and UL4 genes (Figure 4.1A).  The McK genome was 
utilized to engineer the McK∆gK31-68 (Figure 4.1B) virus using the two-step red-mediated 
recombination (Tischer et al., 2006).  Subsequently, a rescued virus (McKR) was constructed 
(Figure 4.1C).  Lack of spurious mutations and confirmation of the engineered mutations was 
obtained by complete genomic sequencing of all engineered viruses (see Materials and 
Methods section).  
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The wild-type (McKrae), McK and the McKR viruses produced on average similar plaque 
sizes on Vero cells (Figure 4.2 A, B, C).  However, the McK∆gK31-68 virus consistently produced 
plaques that were on average approximately half-the-size of the McK and the McKR viruses 
(Figure 4.2D).  The McK∆gK31-68 smaller plaque size phenotype was reversed on the gK 
expressing cells VK302 on which all viruses produced on average similar size plaques (Figure 4.2 
I, J, K, L).  As expected, only the McK virus exhibited EGFP fluorescence (Figure 4.2 F, N).  The 
McK, McK∆gK31-68 and McKR viruses replicated with similar kinetics in Vero cells at an MOI of 
1 with the exception that the McK∆gK31-68 appeared to have a delay in infectious virus 
production at 6 hpi in comparison to the McK and McKR viruses that did not negatively affect 
infectious virus production at later times post infection (Figure 4.3). 
 
Figure 4.1:  Schematic representation of mutant viruses.  The top line represents the prototypic 
arrangement of the HSV-1 genome with the unique long (UL) and unique short (US) regions 
flanked by the terminal repeat (TR) and internal repeat (IR) regions. (A) McK.  (B) McK∆gK31-68.  
(C) McKR.  
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Figure 4.2:  Plaque morphology of the constructed viruses.  Confluent monolayers of Vero cells 
were infected at an MOI of 0.001 and representative plaques were identified and visualized 
after immunhistochemical staining (see Materials and Methods).  Representative viral plaques 
of HSV-1(McKrae) and the derived mutant viruses are shown (A-D & I-L). Representative 
fluorescent plaques were visualized using fluorescence microscopy (E-H & M-P). 
 
Mouse eye infections 
Mice corneas were scarified and infected with 105 pfu for each eye.  The ensued 
development of clinical ocular changes and disease progression were monitored and scored. 
The first signs of ocular changes started to appear at 4 dpi characterized by blepharospasms 
and small amounts of ocular discharges. These symptoms progressed and peaked at 7-8 days 
post infection. The clinical symptoms regressed and started to wane until relative resolution at 
30 dpi. Specifically, the ocular clinical symptoms of blepharoconjunctivitis, hyperemia, keratitis 
and ocular discharge were the criteria used for scoring (see Materials and Methods section). 
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Figure 4.3:  Replication kinetics of parental and mutant viruses.  Confluent monolayers of Vero 
cells were infected at an approximate MOI of 1 with McK, McKR, or McK∆gK31-68 viruses. 
Infection was halted at the indicated time points and viral titers were obtained. 
 
Infection of mouse eyes with the McK virus produced progressive ocular changes 
characterized as mild clinical ocular symptoms (score 1) at 3 days post infection (dpi), moderate 
blepharitis, hyperemia and ocular discharge (score 2) at 6 dpi, and acute ocular disease (score 
3) at 9 dpi. In contrast mock-infected eyes, or eyes infected and observed immediately after 
infection, had no apparent ocular changes and were scored as 0 (Figure 4.4 A, B, C, D).  Mouse 
eyes infected with the McK∆gK31-68 virus did not show any significant ocular disease 
symptoms throughout the thirty-day-long observation post infection (not shown). 
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Figure 4.4:  Clinical ocular disease development and scoring:  Representative photographs of 
eyes exhibiting different lesion scores are shown. Scoring criteria included the degree of 
blepharoconjunctivitis, hyperemia, keratitis and ocular discharge (A) Score 0:  Normal.  (B) Score 
1; Mild. (C) Score 2; Moderate.  (D) Score 3; Severe. 
 
TG-associated viral DNA and infectious virions 
The TG were collected from mice at 30 dpi and tested for the presence of viral DNA 
genomes by qPCR, as we have described previously (David et al., 2012).  Over 600 viral DNA 
genomes were detected in the TGs of mice infected with McK, or the McKR viruses; however, 
no viral DNA was detected in the TGs of mice infected with McK∆gK31-68, or mice in the mock-
infected groups (Figure 4.5 A).  
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TG explants were co-cultured with permissive cells (Vero cells) for 48 hrs to allow for 
viral reactivation.  Infectious viral particle recovery was assessed by the standard plaque assay. 
All TGs from mice infected with McK and 70% of TGs from mice infected with McKR produced 
high numbers of infectious viral particles. However, substantially lower numbers of infectious 
virions were recovered only from two-of-ten of the mice infected with the McK∆gK31-68 virus 
(Figure 4.5 B). 
 
Figure 4.5:  Viral DNA genome detection by qPCR and infectious viral particle recovery from 
TGs.  A) TG samples were taken 30 dpi.  The Viral DNA copy numbers were determined by qPCR.  
Purified plasmid containing the gD gene was used to generate the standard curve. B) Trigeminal 
ganglia explants were triturated and co-cultured with permissive cells (Vero cells) and viral 
titers were obtained by standard titration plaque assay on Vero cells. TG samples were 
collected 30 dpi. 
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Discussion 
We have demonstrated previously that HSV-1 gK plays a pivotal role in neuronal 
infection and the ability of the virus to translocate in a retrograde manner from infected mouse 
corneas to the TG, while lack of gK also prevents virus to be transported in an anterograde 
manner (David et al., 2008; David et al., 2012). The purpose of the present study was to 
investigate whether a relatively small deletion in the amino terminus of gK, which is known to 
bind to the amino terminus of gB and modulate gB’s fusogenic properties, could confer similar 
defects in neuronal infection and spread observed by viruses lacking gK gene expression.  The 
results presented herein show that the amino terminal segment of gK spanning amino acids 31-
68 that includes two N-glycosylation sites is required for neuronal infection and acute 
inflammatory responses responsible for herpes keratitis. 
Previous studies using the HSV-1(F) genome cloned as a bac have identified the amino 
terminus of gK as an important determinant for virus-induced cell fusion, virus entry and virus 
spread (Chouljenko et al., 2009; Chowdhury et al., 2013; Foster et al., 2008; Foster et al., 2001b; 
Jambunathan et al., 2011; Jayachandra et al., 1997).  However, HSV-1(F) does not cause 
significant ocular disease in the mouse eye model (not shown).  Therefore, we have chosen to 
work with the human HSV-1(McKrae) viral strain, because it causes acute disease and death in 
experimental infections of mice via the eye route with or without cornea scarification (David et 
al., 2008).  The HSV-1(McKrae) was cloned as a bac (McKbac) to facilitate the isolation of 
recombinant viruses using the double-red mutagenesis procedure (Tischer et al., 2006).  
Insertion of the bac between the UL3 and UL4 genes appeared to reduce virus-induced 
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mortality in an infectious dose dependent manner (not shown); however the McK remained 
highly pathogenic inducing acute herpes keratitis in infected mouse eyes.  In agreement with 
previous findings using the HSV-1(F) virus, deletion of aa 31-68 from the amino terminus of gK 
did not drastically impair the virus ability to produce infectious virions (Chouljenko et al., 2009).  
We chose to scarify the mouse eyes prior to infection in order to expose a significant 
number of neuronal axonal termini embedded within mouse corneas to direct infection by the 
virus.  The cornea is one of the most densely innervated tissues in the mouse and human body. 
This highly innervated tissue protects the cornea and the eye from the external environment 
(Belmonte and Gallar, 1996; Wang et al., 2012).  Cross-hatching scarification exposes a 
significant number of axons to direct viral infection. Surprisingly, infection of scarified mouse 
eyes with the McK∆gK31-68 virus failed to efficiently infect mouse TG, in comparison to the 
parental virus.  Specifically, qPCR failed to detect viral DNA in mouse TGs; however, very low 
numbers of virions were recovered in 2-of-10 mice infected with the McK∆gK31-68 virus.  This 
discrepancy is attributed to the inability of qPCR to reproducibly and reliably detect less than 50 
copies of viral genomic DNA in ganglionic extracts (not shown), while explant-reactivation co-
culture experiments can amplify a low number of virions during the ganglia incubation at 37° C 
(48 hours) and during the subsequent co-culture on Vero cells (48 hours). Thus, few reactivating 
genomes can result in the observed titers produced by explant culture of the two McK∆gK31-68 
virus-positive mouse ganglia.   
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Importantly, mice infected with McK developed severe blepharoconjuctivitis, 
hyperemia, keratitis and marked ocular discharge 7-8 days post infection. Whereas, mice 
infected with McK∆gK31-68 virus did not show significant clinical ocular changes.  These results 
suggest that efficient translocation of the virus to TG may be prerequisite to the causation of 
acute inflammatory responses and herpes keratitis.  It has been reported that immunization of 
mice with gK significantly exacerbated inflammation, corneal scaring and facial dermatitis 
following ocular HSV-1 infection (Ghiasi et al., 1995; Ghiasi et al., 1997; Ghiasi et al., 1994a; 
Ghiasi et al., 1994b).  Therefore, it is also possible that the amino terminus of gK is involved in 
the induction of innate immune responses that result in acute inflammation and herpes 
keratitis.  This hypothesis is also supported by the observations that a recombinant virus 
expressing extra copies of gK caused elevated levels of inflammation and corneal scaring in 
both mice and rabbits (Mott et al., 2007b).  Moreover, it was reported that elevation of anti-gK 
antibody in individuals with a history of HSV-1 recurrence was correlated with increased 
severity of eye disease (Mott et al., 2007a).  Additional experiments are required to elucidate 
the role of gK in neuronal infection and herpes keratitis. 
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CHAPTER V: CONCLUDING REMARKS 
Summary 
Herpes simplex virus type 1 (HSV-1) is a neurotropic pathogen of humans responsible 
for a wide spectrum of clinical disease, ranging from vesicular lesions on the lips to sight 
threatening keratitis, and fatal encephalitis and disseminated disease. The hallmark of the HSV-
1 life cycle is infection of sensory neurons, where the virus establishes a latent infection for the 
life of the host (Roizman et al., 2007). 
HSV-1 viral particle consists of a double stranded DNA genome enclosed in an 
icosahedral capsid. The capsid is surrounded by a proteinaceous tegument and an envelope 
derived from cell membranes. The viral envelope is studded with 12 glycoproteins that function 
in multiple aspects of viral life cycle and host interaction (Roizman et al., 2007).   
Glycoprotein K (gK) is an envelope glycoprotein that has been the main focus of my PhD 
research work. Specifically, I studied the role of gK and its functional domains in neuroinvasion 
and immunopathogenesis of keratitis. Glycoprotein K has been shown to be involved in viral 
envelopment, fusion, egress and spread (Hutchinson et al., 1992; Hutchinson and Johnson, 
1995; Jambunathan et al., 2011; Jayachandra et al., 1997; Melancon et al., 2005). Other 
glycoproteins such as gE, gM and the membrane protein UL11 have also been shown to play 
roles in viral envelopment, fusion, egress and spread (Chouljenko et al., 2012; Han et al., 2012; 
Kim et al., 2013; Leege et al., 2009). To explore the relative importance of these membrane 
proteins (gK, gE, gM, and UL11) in infection of mouse corneas and establishment of latency in 
ganglionic neurons, we constructed recombinant mutant viruses that lack the expression of 
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either gK, gE, gM, and UL11 and compared them to the wild type parental virus. The 
recombinant viruses were constructed using a markerless two-step Red-mediated 
recombination system implemented on a bacterial artificial chromosome (BAC). The mutant 
viruses were sequenced to assure that no collateral extraneous mutations were introduced. 
The wild type and the recombinant viruses were used to infect mice via the ocular route. The 
mutant viruses were also characterized by using plaque morphology to assess virus spread, viral 
growth kinetics to measure infectious virus production, viral shedding in tear film after ocular 
inoculation, quantitative PCR analysis for the quantification of viral genome copy numbers in 
the trigeminal ganglia.  The wild type virus and all the recombinant viruses except gK-null 
mutant were able to infect axonal termini embedded in the cornea and establish latency in 
ganglionic neurons albeit with varied efficiency. This result suggests that gK plays the most 
important role in neuroinvasiveness. UL11-null virus replicated in the eyes less efficiently than 
gM-null and gE null mutants, however, it infected ganglionic neurons and established latency 
more efficiently than either the gM or gE-null viruses (Kim et al., 2014).  
Recent work in this research laboratory has shown that gK is essential for viral corneal 
spread and neuroinvasiveness (David et al., 2008). Previously, I participated in the development 
of a primary neuronal culture system to study the role of gK in axonal infection and viral 
transport in retrograde and anterograde manner in neurons. Primary neuronal cultures were 
prepared from the dorsal root ganglia of embryonic rats. A single cell suspension of neurons 
was plated in microfluidic devices that separate neuronal bodies from pure axonal fraction. We 
utilized this microfluidic system to show that gK is required for infection of axonal termini and 
egress from neuronal cell bodies in primary neuronal cultures (David et al., 2012).  
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The above mentioned investigations revealed that deletion of the entire gK gene 
resulted in drastic decrease in viral replication and spread efficiencies. A viral backbone that 
lacks gK constitutes a safe viral vector; however, low replication and spread efficiencies would 
be considered major disadvantages. Therefore, I sought to delineate gK domains responsible for 
neuroinvasion and replication as well as immunopathogenesis of keratitis. The highly 
pathogenic and neuroinvasive clinical ocular isolate of HSV-1 McKrae strain, was used to 
construct a recombinant mutant virus lacking 37 amino acids from the amino terminus of gK, 
amino acids (31-68). This recombinant virus and its parent wild type were characterized by 
using plaque morphology to assess virus spread, viral growth kinetics to measure infectious 
virus production, and by quantitative PCR analysis for the quantification of viral genome copy 
numbers in the trigeminal ganglia. Experiments in this investigation (outlined in chapter IV of 
this dissertation) showed that the amino terminus of gK is dispensable for replication in tissue 
culture, but important for neuroinvasion and establishment of latency after ocular inoculation 
of mice (Saied et al., 2014).  
One important observation from the above investigation is that mice infected with the 
wild type virus developed severe keratitis, conjunctivitis, blepharitis and ocular discharge. On 
the other hand, mice infected with the recombinant virus lacking the amino terminus of gK did 
not exhibit significant ocular changes (Saied et al., 2014). This observation suggests a potential 
role for the amino terminus of gK in immunopathogenesis of keratitis. The investigation of the 
role of the amino terminus of gK in immunomodulation of keratitis is currently in progress. The 
preliminary results obtained so far are included in Appendix I.  
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In conclusion, the research work in this dissertation is considered a significant 
contribution to our understanding of alphaherpesvirus virulence factors and neurotropic 
determinants. It may lead to the development of a safe, replication competent viral vector 
backbone for oncolytic viral therapy and vaccine. The research work presented in this 
dissertation may also lead the discovery of new therapeutics to treat herpes keratitis, and to 
find new ways to combat neuronal infections.  
Current and Future Research 
Current work is focused on answering another critical question; is gK that lacks the 37 
amino acids from the amino terminus expressed on the virion particle? To answer this question, 
I have constructed a recombinant virus that has a deletion in the amino terminus of gK and also 
carries a V5 tag on its carboxyl terminus. gK is extremely hydrophobic, and notoriously difficult 
to detect. The purpose of tag insertion is to facilitate detection in various types of experiments. 
Sequencing of this virus showed that the V5 tag is inserted in the intended location and that no 
amino acid changing mutations were introduced.  We are currently working on showing the 
expression of tagged gK (31-68) in the virion particle by western blot analysis on purified 
virions. Concurrently, I am studying the mechanism by which gK is involved in 
immunomodulation of keratitis (please see Appendix I). 
The work in this dissertation raised important research questions about the critical 
amino acid requirements in the amino terminus of gK that are responsible for neuroinvasion 
and immunopathogenesis. Glycoprotein K is post-translationally modified by N-linked 
carbohydrate addition at the amino-terminus.  The segment spanning amino acid (aa) 31 to aa 
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68 in the amino terminus of gK contains two N-linked glycosylation sites at aa 48 and aa 58. 
Future research could delineate the gK critical amino acids and the role of N-glycosylation in gK 
function.    
Another interesting and very important question to address is the mechanism by which 
gK functions in virion entry at the axonal termini.  This research question can be investigated by 
studying the effects of gK mutations on gB conformation, and by assessing the role of cellular 
receptors and signaling pathways in gK-mediated virus entry into axonal termini.  
The secondary structure of gK presents Domain II as a loose cytoplasmic domain with a 
couple of membrane anchored amino acids. However, the modeled tertiary structure of gK 
predicts that Domain II is composed of two connected alpha helices. This is particularly 
interesting because it reveals that this portion may not be a mere structural domain. It may also 
have an important function which merits further investigation. 
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APPENDIX I: ADDITIONAL WORK 
Introduction 
HSV-1 causes multiple medical disorders such as cold sore, keratitis, encephalitis and 
systemic disease (Roizman et al., 2007; Whitley et al., 1998). It is the leading infectious cause of 
corneal blindness in the US. An estimated 400,000 people in the US suffer from herpes simplex 
ocular disease, with about 50,000 new or recurrent cases occurring annually. HSV-1 infects 
sensory neurons and establishes a latent infection in the trigeminal ganglia (Roizman et al., 
2007; Whitley et al., 1998). Reactivation of latent virus from the trigeminal ganglia can cause 
spread to corneal transplants causing corneal graft failure (Cockerham, 2001). 
The envelope of the HSV-1 virion particle contains 12 glycoproteins as well as several 
membrane-associated proteins, which play important roles in viral entry and virus-induced cell 
fusion (Roizman et al., 2007) . HSV-1 glycoprotein K (gK) is a structural component of the virion 
particle and functions in virus entry into epithelial cells (Foster et al., 2001; Jambunathan et al., 
2011) cytoplasmic virion envelopment, virion egress, and virus-induced cell fusion (Chouljenko 
et al., 2009). Glycoprotein K exerts its function in virus entry by modulation of gB, the bona fide 
fusogen of HSV-1 (Chouljenko et al., 2009). HSV-1 gB has been shown to interact with TLR-2 
which leads to pro-inflammatory cytokine production via MyD88 dependent signaling (Cai et al., 
2013).  
Corneal epithelial cells are one of the most important participants in herpes simplex 
keratitis (HSK). They not only take part in pathogen recognition via the expression of a wide 
range of pattern recognition receptors (PRR) including Toll-like receptors (TLR) TLR-2, and TLR-
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7, but also secrete β-defensins, cytokines and chemotactic factors upon microbial invasion 
(Johnson et al., 2005; Kumar et al., 2006).  
We have reported that mice infected with wild type virus (wt) exhibited significant 
clinical ocular changes and keratitis while mice infected with a recombinant virus lacking the 
amino terminus of gK (McK ∆gK 31-68) did not show significant ocular disease (Saied et al., 
2014) (Figure AI.1). In this work, we describe a novel immuno-modulatory role for gK in the 
immunopathogenesis of HSK. 
               
Figure AI.1: Ocular infection of mice. Infection of mice eyes with the wt virus produced 
progressive ocular changes characterized by severe blepharitis, keratitis, hyperemia and ocular 
discharge seen in top right panel. Histopathological examination of the eyes revealed that the 
cornea is infiltrated by a large number of neutrophils, lymphocytes, plasma cells and 
macrophages and neovascularization is noted, bottom right panel. Infection of mice eyes with 
McK ∆gK 31-68 virus produced no significant ocular disease shown in top left panel. The cornea 
shows no significant histopathological changes in eyes infected with McK ∆gK 31-68 virus, 
bottom left panel. L: lens, C: cornea, E: 3rd eylid. 
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Objectives and Hypothesis 
The objective of this work is to investigate the role of the amino terminus of gK in the 
induction of the innate signaling pathways that are involved in herpes immunopathogenesis of 
keratitis. We hypothesize that the lack of the amino terminus of gK alters gB binding to TLR-2 
which leads to TLR-2 mediated immunomodulation. 
Materials and Methods 
Viruses 
The highly pathogenic and neuroinvasive wild type HSV-1 virus McKrae strain cloned 
onto a bacterial artificial chromosome plasmid vector (designated as wt) was used as a back 
bone to construct a recombinant virus that lacks the amino terminus of glycoprotein K 
(designated as McK ∆gK 31-68) virus. Two-step red mutagenesis implemented on the wt virus 
was performed to construct McK ∆gK 31-68 virus.  
Toll-like receptor-2 (TLR2) stimulation 
HEK-Blue™-hTLR2 cells (bought from InvivoGen) were used to study the stimulation of 
TLR2 by monitoring the activation of NF-kB. HEK-Blue™-hTLR2 cells are HEK293 cells co-
transfected with human TLR2 (hTLR-2) and SEAP (secreted embryonic alkaline phosphatase) 
reporter genes. Levels of SEAP were determined using a detection medium with SEAP substrate 
QUANTI-Blue™. The hydrolysis of the substrate by SEAP produces a purple/blue color that can  
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be measured with a spectrophotometer. HEK-Blue™ Null1 cell line (bought from InvivoGen) is 
the parental cell line of HEK-Blue™ hTLR2. HEK-Blue™ Null1 cells lack the expression of TLR-2 
but express the SEAP reporter gene. 
QPCR analysis 
qPCR analysis to determine the levels of mRNA transcription of pro-inflammatory 
cytokines and interferon genes was performed on; HEK-Blue™-hTLR2 cells, HEK-Blue™ Null1 
cells and Human corneal epithelial (HCE) cells lysates. The pro-inflammatory cytokines and 
interferon genes; TNF- α, IL-6, IL-10, and IFN-B were selected for the qPCR procedure. 
Detection of NF-kB activation by western blot 
Western blot analysis was performed on human corneal epithelial cells to determine the 
activation of the transcription factor NF-kB using IKB-α as a proxy for NF-kB activation. 
Antibodies for IKB- α detection were purchased from abcam, USA.  
Results 
Toll-like receptor-2 (TLR2) stimulation 
McK ∆gK 31-68 virus induces marked NF-kB activation in HEK-Blue-TLR2 cells compared 
to wt virus. There is no marked difference in NF-kB activation between wt virus and McK ∆gK 
31-68 virus in infected HEK-Blue Null1 cells (Figure AI.2).  
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Figure AI.2: NF-kB activation. HEK-Blue-TLR2 and HEK-Blue Null1 cells were infected with either 
McK ∆gK 31-68 virus or wt virus, a detection medium with SEAP substrate was added to the 
Supernatants from infected cells were added 18 hrs post infection. Changes in optical density 
were measured by a spectrophotometer.   McK ∆gK 31-68 virus causes 8-8.5 fold increase in 
optical density in HEK-Blue-TLR2 cells compared to wt virus. Activation levels of NF-kB in HEK-
Blue Null1 cells are similar for both viruses. TLR-2: HEK-Blue-TLR2 cells. Null: in HEK-Blue Null1 
cells. 
QPCR analysis for pro-inflammatory cytokine mRNA transcripts in HEK blue cells 
Lack of the amino-terminus of gK is associated with increased pro-inflammatory 
cytokine mRNA levels in HEK-Blue-TLR2 cells (Figure AI.3). Greater mRNA levels of TNF- α, IL-6 
and IFN- β were detected in HEK-Blue-TLR2 cells infected with McK ∆gK 31-68 compared to wt 
virus. Generally, mRNA levels of TNF- α and IFN- β were similar in HEK-Blue™ Null1 cells 
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infected with McK ∆gK 31-68 compared to wt virus. The production of large numbers of pro-
inflammatory cytokine and IFN-β mRNA transcripts after NF-kB activation is overwhelmingly 
due to TLR-2 pathway engagement in HEK Blue cells (Figure AI.4).  
Figure AI.3: QPCR analysis-HEK blue cells. HEK Blue TLR-2 and HEK Blue Null1 cells were infected 
at a multiplicity of infection (MOI) of 5 with either wt or McK ∆gK 31-68 virus. RNA was 
extracted at multiple different points post infection and mRNA transcripts copy numbers of pro-
inflammatory cytokines were determined by QPCR. TLR-2: HEK-Blue-TLR2 cells. Null: HEK-Blue 
Null1 cells. Asterisks denote statistical significance. Threshold significance level is 0.05. HPI: 
hours post infection. 
Determination of NF-kB activation in HCE by western blot 
McK ∆gK 31-68 virus prompts more NF-kB activation than the WT virus at early time 
points in HCE cells (Figure AI.5). 
QPCR analysis for pro-inflammatory cytokine mRNA transcripts in HCE cells 
Lack of the amino-terminus of gK is associated with increased pro-inflammatory 
cytokine mRNA levels in HCE cells (Figure AI.6). TNF- α and IL-6 mRNA transcripts were 
significantly higher in HCE cells infected with the McK ∆gK 31-68 than cells infected with the wt 
virus. 
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Figure AI.4: QPCR analysis, TLR-2 engagement. Since NF-kB can be activated by TLR-2 
engagement as well as other pathways, we divided mRNA transcription levels obtained from 
infection of HEK Blue-TLR-2 cells by the mRNA transcription levels obtained from infection of 
HEK Blue Null1 cells. This will help distinguish the impact of TLR-2 engagement in the activation 
of NF-kB and the production of inflammatory cytokine and IFN-β. TLR-2: HEK-Blue-TLR2 cells. 
Null: HEK-Blue Null1 cells. Asterisks denote statistical significance. HPI: hours post infection. 
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Figure AI.5: Western blot for NF-kB activation in HCE cells. IKB-α was used as a proxy for NF-kB 
activation. McK ∆gK 31-68 virus induces more NF-kB activation than wt virus at early time 
points. HCE cells: Human corneal epithelial cells. 
 
 
Figure AI.6: QPCR analysis-HCE cells.  HCE cells were infected at a multiplicity of infection (MOI) 
of 5 with either wt or McK ∆gK 31-68 virus. RNA was extracted at multiple different time points 
post infection and mRNA transcripts copy numbers of pro-inflammatory cytokines were 
determined by QPCR. Asterisks denote statistical significance. Threshold significance level is 
0.05. HPI: hours post infection. HCE: human corneal epithelial cells. 
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Summary 
Lack of the amino-terminus of gK alters NF-kB activation which indicates that gK is 
potentially involved in the immunomodulation of herpes keratitis. McK ∆gK 31-68 induces 
marked NF-kB activation than the wt virus. Subsequently, greater pro-inflammatory cytokine 
mRNA transcripts were detected in cells infected with McK ∆gK 31-68 than the wt virus at early 
time points. The global gene expression dynamics of viral as well as host mRNA transcripts are 
being studied using digital PCR and RNA seq. Lack of the amino terminus of gK my alter gB 
binding to TLR-2 which leads to TLR-2 mediated immunomodulation. Future studies may 
involve the detection of conformational changes in gB using a cadre of monoclonal antibodies 
and confirm of the engagement of TLR-2 pathway. 
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